Industries > Pharma > Ophthalmic Drugs Market Report to 2030
Ophthalmic Drugs Market Report to 2030
Forecasts by Indication (Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs), by Type (Prescription Drugs, OTC Drugs), by Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Ophthalmic Drugs Companies AND COVID-19 Recovery Scenarios
• Discover the impact of COVID-19 and the subsequent recession/ economic recovery on the Ophthalmic drugs market.
• Realize which global markets are set to be most profitable over the next 10 years for ophthalmic drugs – will the US still dominate this market?
• Unearth which of the new ophthalmic medications (treating glaucoma, waterfall, diabetic retinopathy, and other ophthalmic problems) – along with novel medications – will be the most effective and biggest sellers over the next decade.
• Establish which of the new mergers, acquisitions and collaborations are changing competitive dynamics today.
Which are your competitors and key players doing this year? This report will tell you.
The global market for ophthalmic drugs is increasing yearly. Your competitors in the ophthalmic drugs market are benefiting from key opportunities – what are they and how can you benefit? This report will tell you.
With product approvals over the next decade set to be a key issue facing all competitors in the market – you must discover the essential strategies being implemented by key market players between 2015 and Jan 2021.
Includes crucial sales predictions for the global ophthalmic drugs market and submarkets along with breakdown by region, country and the impact of COVID-19 on those markets. Also included is key segmentation analysis of the ophthalmic drugs market, with forecasts across disease type, infections and distribution channels. Products are forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.
To access the data contained in this document please email contactus@visiongain.com
Leading companies and the potential for market growth
As per Visiongain analysis, global ophthalmic drugs market is estimated to be valued at US$xx in 2021 and is projected to reach at a market value of US$xx by 2031. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Why You Should Buy Visiongain Report only?
The report study aims to explore the market drivers, restraints and also market opportunities facing dermatological drugs product stakeholders in different geographic areas. Also, it identifies trends, gaps, and opportunities in each micro market segment. Finally, this report identifies the major stakeholders, product portfolios, and recent developments in order to draw a competitive landscape for players in this market.
This unique limited edition report also includes exclusive analysis by
By Indication
• Dry Eye
• Glaucoma Drugs
• Retinal Disorders Drugs
• Allergic, Inflammatory & Infective Drugs
• Others
By Type
• Prescription Drugs
• OTC Drugs
By Distribution Channel
• Hospital Pharmacies
• Drug Stores
• Online Pharmacies
By Region
• North America
– U.S.
– Canada
• Europe
– Germany
– France
– United Kingdom
– Italy
– Spain
– Russia
– Poland
– Rest of Europe
• Asia Pacific
– China
– Japan
– India
– Australia
– South Korea
– Rest of Asia Pacific
• Latin America
– Brazil
– Mexico
– Rest of Latin America
• Middle East & Africa
– Saudi Arabia
– South Africa
– UAE
– Rest of Middle East & Africa
Need industry data? Please contact us today.
This report includes revenue forecasts over the next decade for the following ophthalmic drugs:
• Eylea
• Lucentis
• Avastin
• Visudyne
• Jetrea
• Pataday
• Vigamox
• Patanol
• TobraDex
• Cravit
• AzaSite
• Acular
• Lumigan and Ganfort
• Xalatan/Xalacom
• Travatan/Travatan Z and DuoTrav
• Alphagan/Alphagan P and Combigan
• Azopt
• Trusopt
• Zioptan
• Cosopt
• Tapros/Taflotan
• Restasis
• Refresh
• Hyalein
• Diquas
A company profile gives you the following information:
• Revenue forecast for ophthalmic drugs 5
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), and collaborations, including alliances, partnerships, and joint ventures
• Discussion of a company’s activities and outlook
• Ophthalmic drugs revenue forecasts
Discover capabilities, progress, and commercial prospects, helping you stay ahead. What effects will regulatory changes have?
Research and development activities – assess innovation, trends and possibilities
What is happening in the R&D pipeline for ophthalmic treatments? You see developmental trends, gaining insight into each phase of the ophthalmology R&D pipeline for:
• Dry eye drugs
• Glaucoma drugs
• Allergic, infective and inflammatory drugs
• Retinal disorder drugs
• Other progress in ophthalmology
With analysis of key ophthalmic drugs market players – such as – Novartis, Regeneron, Allergan, Roche, Santen Pharmaceutical Co., Bayer, Pfizer, Senju Pharmaceutical Company Ltd (Senju), Bausch Health Companies Inc., Akorn, Inc., Sun Pharmaceutical Industries Ltd., Aerie Pharmaceuticals Inc, Biogen
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Ophthalmic Drugs Market Report to 2030: Forecasts by Indication (Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs), by Type (Prescription Drugs, OTC Drugs), by Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Ophthalmic Drugs Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Ophthalmic Drugs Market Overview
1.2 Global Ophthalmic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Ophthalmic Drugs
2.1. The Pharmaceutical Industry: Very Brief Overview
2.2 Structure and Function of the Eyes
2.3 The Global Burden of Eye Disease
2.4 Vision Impairment
2.5 Ophthalmic Drugs: Market Segmentation
2.6 Glaucoma: A Major Cause of Vision Loss
2.6.1 A Classification of Glaucoma
2.6.2 Primary Open-Angle Glaucoma
2.6.3 Acute Angle-Closure Glaucoma
2.6.4 Congenital Glaucoma
2.6.5 Secondary Glaucoma
2.6.6 Normal-Tension Glaucoma
2.6.7 Ocular Hypertension
2.7 Risk Factors for Glaucoma
2.8 Diagnosis of Glaucoma
2.9 Drug Treatment of Glaucoma
2.10 Laser Treatment and Surgery for Glaucoma
2.11 Age-Related Macular Degeneration (AMD)
2.11.1 Dry (non-exudative) AMD
2.11.2 Wet (exudative) AMD
2.11.3 Risk Factors for AMD
2.11.4 Diagnosis of AMD
2.11.5 Treatment of AMD
2.12 Diabetic Retinopathy (DR)
2.12.1 Diagnosis of Diabetic Retinopathy
2.12.2 Treatment of Diabetic Retinopathy
2.13 Ocular Allergy and Allergic Conjunctivitis
2.13.1 Diagnosis of Ocular Allergy
2.13.2 Treatment of Ocular Allergy
2.14 Ocular Inflammatory Disease
2.14.1 Treatment of Ocular Inflammatory Disease
2.15 Eye Infections
2.15.1 Treatment of Eye Infections
2.16 Dry Eye Syndrome
2.16.1 Treatment of Dry Eye Syndrome
2.17 Phases of Clinical Trials
2.18 Impact of Covid-19 on Ophthalmic Drugs Market
3. Qualitative Analysis of the Ophthalmic Drugs Market, 2020-2030
3.1 Market Factors Influencing Ophthalmic Drugs
3.2 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
3.2.1 Strengths
3.2.1.1 Strengths Healthy R&D Pipeline
3.2.1.2 Advances in Drug Delivery Technologies
3.2.1.3 Support for Reimbursement and Payment Approvals
3.2.1.4 Gene Therapy and RNAi Technology
3.2.1.5 New Ophthalmic Therapeutic Applications for Drugs
3.2.1.6 Development of Neuroprotective Anti-Glaucoma Medications
3.2.1.7 Biomarkers as Tools for Better Diagnosis and Treatment
3.2.2 Weaknesses
3.2.2.1 Low Levels of Patient Adherence to Treatment
3.2.2.2 High Treatment Burden on Patients and Healthcare Providers
3.2.2.3 Under-Diagnosis and Under-Treatment
3.2.3 Opportunities
3.2.3.1 Sustained-Release Ocular Implants
3.2.3.2 The Impact of a Rapidly Ageing Global Population
3.2.3.3 Increasing Prevalence of Diabetes and Ocular Disease
3.2.3.4 Glaucoma and Retinal Disorders Set for Most-Marked Increases in Prevalence
3.2.3.5 Unmet Clinical Need in Many Disease Areas
3.2.3.6 Economic Growth in Emerging Market Provide Opportunity for Expansion
3.2.4 Threats
3.2.4.1 Intensifying Price Regulation in The Market
3.2.4.2 Generic Competition – Likely to Cause Erosion of Sales for Market Leading Brands
3.2.4.3 Rising Cost Of R&D
3.2.4.4 Biosimilars – A Bigger Threat than Generics?
3.3 Porter’s Five Force Analysis of The Global Ophthalmic Drugs Market, 2020-2029
3.3.1 Threat of New Entrants
3.3.2 Rivalry Among Competitors
3.3.3 Power of Suppliers
3.3.5 Power of Buyers
3.3.5 Power of Buyers
3.4. PESTEL Analysis
4. Ophthalmic Drugs Market, 2020-2030
4.1 Global Ophthalmic Drugs Market Overview
4.2 Categorizations of the Global Ophthalmic Drugs Market
4.3 Global Ophthalmic Drugs Market Overview
4.4 Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
4.5 Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6 Global Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
4.6.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.6 Pre-Covid Prescription Drugs: Revenue Forecast, 2020-2030
4.6.7 V-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.8 U-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.9 L-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.10 W-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.11 Pre-Covid OTC Drugs: Revenue Forecast, 2020-2030
4.6.12 V-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.13 U-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.14 L-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.15 W-Shaped RecoveryOTC Drugs: Revenue Forecast, 2020-2030
4.7 Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.1 Pre-Covid Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.6 Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.1 Pre-Covid Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.2 V-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.3 U-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.4 L-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.5 W-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.7 Drug Stores: Revenue Forecast, 2020-2030
4.7.7.1 Pre-Covid Drug Stores: Revenue Forecast, 2020-2030
4.7.7.2 V-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.3 U-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.4 L-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.5 W-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.8 Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.1 Pre-Covid Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.2 V-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.3 U-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.4 L-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.5 W-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.8 Covid-19 Impact on Ophthalmic Drugs Market
5. Retinal Disorder Drugs Market, 2020-2030
5.1 Global Retinal Disorder Drugs Market Overview
5.2 Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.1 Pre-Covid Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.2 V-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.3 U-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.4 L-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.5 W-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.3 Trend of Retinal Diseases in Developing Countries
5.4 Has Monotherapy Reached Its Limit?
5.5 Technologies that could transform the treatment of blindness
5.5.1 How Likely Is Avastin’s Expansion into Age-Related Macular Degeneration?
5.6 Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.6.1 Pre-Covid Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.7. Eylea (aflibercept) - Regeneron/ Bayer/ Santen: Revenue Forecast, 2020-2030
5.7.1 Eylea/Zaltrap and the Davis-Smyth Patent Agreements
5.7.2 Possible Combination Therapies Involving Eylea
5.8 Lucentis (ranibizumab) – Roche/ Novartis: Revenue Forecast, 2020-2030
5.8.1 Lucentis Approvals for New Indications
5.9 Avastin (bevacizumab) - Roche: Revenue Forecast, 2020-2030
5.9.1 Very low-dose Avastin may help prevent retinopathy of prematurity
5.9.2 Avastin Repackages Must Meet New Guidance
5.10 Visudyne (verteporfin) - Valeant/ Novartis: Revenue Forecast, 2020-2030
5.11 Jetrea (ocriplasmin) - ThromboGenics/ Novartis: Revenue Forecast, 2020-2030
5.12 BEOVU (brolucizumab-dbll): Revenue Forecast, 2020-2030
5.13 Other Retinal Disorder Drugs
5.13.1 Iluvien (fluocinolone implant) - Alimera Sciences
5.13.2 Ozurdex (dexamethasone implant) – Allergan
5.14 Covid-19 Impact on Retinal Disorder Drugs Market
5.15.1 V-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.2 U-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.3 L-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.4 W-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
6. Allergic, Inflammatory & Infective Drugs Market, 2020-2030
6.1 Global Allergic, Inflammatory & Infective Drugs Market Overview
6.2 Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.1 Pre-Covid Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.2 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.3 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.4 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.5 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.3 Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.4 Patanol And Pataday (olopatadine) - Alcon (Novartis)
6.4.1 Pataday: Revenue Forecast, 2020-2030
6.4.2 Patanol: Revenue Forecast, 2020-2030
6.4.3 Approval of Pazeo Solution
6.5 Vigamox (moxifloxacin) – Alcon (Novartis): Revenue Forecast, 2020-2030
6.5.1 Intensifying Competition and Generics Drug Challenge to Vigamox
6.6 TobraDex (tobramycin/dexamethasone) - Eyevance Pharmaceuticals: Revenue Forecast, 2020-2030
6.7 Cravit (levofloxacin) - Santen: Revenue Forecast, 2020-2030
6.8 Acular (ketorolac) – Allergan: Revenue Forecast, 2020-2030
6.9 AzaSite (azithromycin): Revenue Forecast, 2020-2030
6.10 Bromday (bromfenac): Revenue Forecast, 2020-2030
6.11 Covid-19 Impact on Allergic, Inflammatory & Infective Drugs Market
6.11.1 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.2 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.3 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.4 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
7. Glaucoma Drugs Market, 2020-2030
7.1 Global Glaucoma Drugs Market Overview
7.2 Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.1 Pre-Covid Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.2 V-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.3 U-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.4 L-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.5 W-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.3 Pre-Covid Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.4 Glaucoma Drugs: Market Trends and Developments, 2020
7.4.1 Patent Expiration: A Major Restraint for Glaucoma Drugs
7.4.2 Innovation in Glaucoma Management
7.5 Lumigan & Ganfort (bimatoprost) – Allergan (Actavis): Revenue Forecast, 2020-2030
7.6 Travatan/Travatan Z & Duotrav (travoprost) - Novartis: Revenue Forecast, 2020-2030
7.7 Alphagan & Combigan: Revenue Forecast, 2020-2030
7.8 Xalatan & Xalacom (latanoprost) - Pfizer: Revenue Forecast, 2020-2030
7.9 Azopt (brinzolamide) - Novartis: Revenue Forecast, 2020-2030
7.10 Cosopt/ Cosopt PF: Revenue Forecast, 2020-2030
7.11 Tapros (tafluprost) – Santen: Revenue Forecast, 2020-2030
7.12 Trusopt: Revenue Forecast, 2020-2030
7.13 Zioptan (Tafluprost): Revenue Forecast, 2020-2030
7.14 Rhopressa (netarsudil): Revenue Forecast, 2020-2030
7.15 Covid-19 Impact on Glaucoma Drugs Market
7.15.1 V-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.2 U-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.3 L-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.4 W-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
8. Dry Eye Drugs Market, 2020-2030
8.1 Global Dry Eye Drugs Market Overview
8.2 Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.1 Pre-Covid Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.2 V-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.3 U-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.4 L-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.5 W-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.3 Pre-Covid Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.4 Dry Eye Drugs: Market Trends and Developments, 2020
8.4.1 Restasis: Patent Elongations and Generic Challenges Creating Uncertainty
8.4.2 Concept of new dry eye diagnosis: tear film-oriented diagnosis
8.5 Restasis: Revenue Forecast, 2020-2030
8.6 Refresh: Revenue Forecast, 2020-2030
8.7 Hyalein: Revenue Forecast, 2020-2030
8.8 Diquas: Revenue Forecast, 2020-2030
8.9 Artelac (Hypromellose) - Bausch + Lomb: Revenue Forecast, 2020-2030
8.10 Others Dry Eye Drugs: Revenue Forecast, 2020-2030
8.11 Covid-19 Impact on Dry Eye Drugs Market
8.11.1 V-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.2 U-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.3 L-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.4 W-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
9. Ophthalmic Drugs Market, 2020-2030, By Region
9.1 Global Ophthalmic Drugs Market Overview
9.2 Pre-Covid Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
9.3 Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.1 Pre-Covid Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
10. North America Ophthalmic Drugs Market, 2020-2030
10.1 North America Ophthalmic Drugs Market Overview
10.2 North America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
10.3 North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.1 Pre-Covid North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.4 North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.1 Pre-Covid North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.5 North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.1 Pre-Covid North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.6 North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.1 Pre-Covid North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.2 U.S. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
10.6.2.1 Is there a big change around the corner?
10.6.3 Canada Ophthalmic Drugs: Revenue Forecast, 2020-2030
10.7 Covid-19 Impact on North America Ophthalmic Drugs Market
10.7.1 V-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.1.1 V-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.1.2 V-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2 U-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.2.1 U-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2.2 U-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3 L-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.3.1 L-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3.2 L-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4 W-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.4.1 W-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4.2 W-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
11. Europe Ophthalmic Drugs Market, 2020-2030
11.1 Europe Ophthalmic Drugs Market Overview
11.2 Europe Ophthalmic Drugs Market: Revenue Forecast 2020-2030
11.3 Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.1 Pre-Covid Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.4 Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.1 Pre-Covid Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.5 Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.1 Pre-Covid Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.6 Pre-Covid Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.6.1 Germany Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.2 France Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.3 U.K. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.4 Italy Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.5 Spain Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.7 Russia Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.8 Poland Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.9 Rest of Europe Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.7 Covid-19 Impact on Europe Ophthalmic Drugs Market
11.7.1 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.1.1 V-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.2 V-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.3 V-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.4 V-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.5 V-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.6 V-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.7 V-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.8 V-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2 UShaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.2.1 U-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.2 U-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.3 U-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.4 U-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.5 U-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.6 U-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.7 U-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.8 U-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.3.1 L-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.2 L-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.3 L-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.4 L-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.5 L-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.6 L-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.7 L-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.8 L-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.4.1 W-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.2 W-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.3 W-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.4 W-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.5 W-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.6 W-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.7 W-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.8 W-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
12. Asia Pacific Ophthalmic Drugs Market, 2020-2030
12.1 Asia Pacific Ophthalmic Drugs Market Overview
12.2 Asia Pacific Ophthalmic Drugs Market: Revenue Forecast 2020-2030
12.3 Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.4 Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.5 Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.6 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.6.1 China Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.1.1 Expansion of Healthcare Coverage and Reimbursement in China
12.6.1.2 Looming crunch for public health insurance
12.6.1.3 Pharmaceutical Pricing Policies in China
12.6.2 Japan Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.2.1 Pharmaceutical Policies and Reform in Japan
12.6.3 India Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.3.1 India: price controls and generic competition
12.6.3.2 Changing Healthcare infrastructure in India
12.6.4 Australia Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.5 South Korea Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.6 Rest of Asia Pacific Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.7 Covid-19 Impact on Asia Pacific Ophthalmic Drugs Market
12.7.1 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.2 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.3 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.4 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.1 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.1.1 V-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.2 V-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.3 V-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.4 V-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.6 V-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.2 UShaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.2.1 U-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.2 U-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.3 U-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.4 U-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.6 U-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.3 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.3.1 L-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.2 L-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.3 L-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.4 L-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.6 L-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.4 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.4.1 W-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.2 W-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.3 W-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.4 W-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.6 W-Shaped Recovery Rest of Asia Pacific Ophthalmic Drugs Market: Forecast 2020-2030
13. Latin America Ophthalmic Drugs Market, 2020-2030
13.1 Latin America Ophthalmic Drugs Market Overview
13.2 Latin America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
13.3 Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.4 Latin America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.1 Pre-Covid Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.2 V-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.3 U-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.4 L-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.5 W-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.5 Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.6 Pre-Covid Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.6.1 Brazil Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.6.2 Mexico Ophthalmic Drugs: Revenue Forecast, 2020-2030
13.6.3 Rest of Latin America Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.7 Covid-19 Impact on Latin America Ophthalmic Drugs Market
13.7.1 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.2 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.3 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.4 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.1 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.1.1 V-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.1.2 V-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.1.3 V-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2 U-shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.2.1 U-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2.2 U-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2.3 U-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.3.1 L-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3.2 L-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3.3 L-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.4.1 W-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4.2 W-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4.3 W-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
14. Middle East & Africa Ophthalmic Drugs Market, 2020-2030
14.1 Middle East & Africa Ophthalmic Drugs Market Overview
14.2 Middle East & Africa Ophthalmic Drugs Market: Revenue Forecast 2020-2030
14.3 Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.4 Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.5 Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.6 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.6.1 Saudi Arabia Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.2 South Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.6.2.1 South Africa: has the Single Exit Price worked?
14.6.3 UAE Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.4 Rest of Middle East & Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.7 Covid-19 Impact on Middle East & Africa Ophthalmic Drugs Market
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1.1 V-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.2 V-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.3 V-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.4 V-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.6 V-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2 U-shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2.1 U-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.2 U-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.3 U-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.4 U-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.6 U-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3.1 L-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.2 L-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.3 L-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.4 L-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.6 L-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4.1 W-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.2 W-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.3 W-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.4 W-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.6 W-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
15. Leading Companies in the Vaccine Contract Manufacturing Market, 2020-2030
15.1 Pre-Covid Leading Companies in the Ophthalmic Drugs Market, 2020
15.2 Novartis
15.2.1 Novartis: Ophthalmic Drugs Portfolio
15.2.2 Novartis AG: Financial Overview
15.2.3 Novartis: Sales Forecast, 2020-2030
15.2.4 Novartis: Ophthalmic Drugs Development Pipeline
15.2.5 Novartis: Recent Developments
15.3 Regeneron
15.3.1 Regeneron: Ophthalmic Drugs Portfolio
15.3.2 Regeneron: Financial Overview
15.3.3 Regeneron: Sales Forecast, 2020-2030
15.3.4 Regeneron: Ophthalmic Drugs Development Pipeline
15.3.5 Regeneron: Recent Developments
15.4 Allergan
15.4.2 Allergan: Financial Overview
15.4.3 Allergan: Sales Forecast, 2020-2030
15.4.4 Allergan: Ophthalmic Drugs Development Pipeline
15.4.5 Allergan: Recent Developments
15.5 Roche
15.5.1 Roche: Ophthalmic Drugs Portfolio
15.5.2 Roche: Financial Overview
15.5.3 Roche: Sales Forecast, 2020-2030
15.5.4 Roche: Ophthalmic Drugs Development Pipeline
15.5.5 Roche: Recent Developments
15.6 Santen Pharmaceutical Co.
15.6.1 Santen: Ophthalmic Drugs Portfolio
15.6.2 Santen: Financial Overview
15.6.3 Santen: Sales Forecast, 2020-2030
15.6.4 Santen: Ophthalmic Drugs Development Pipeline
15.6.5 Santen: Recent Developments
15.7 Bayer
15.7.1 Bayer: Ophthalmic Drugs Portfolio
15.7.2 Bayer: Financial Overview
15.7.2 Bayer: Financial Overview
15.8 Pfizer
15.8.1 Pfizer: Ophthalmic Drugs Portfolio
13.8.2 Pfizer: Financial Overview
15.8.3 Pfizer: Sales Forecast, 2020-2030
15.8.4 Pfizer: Ophthalmic Drugs Development Pipeline
15.8.5 Pfizer: Recent Developments
15.9 Senju Pharmaceutical Company Ltd (Senju)
15.9.1 Senju: Ophthalmic Drugs Portfolio
15.9.2 Senju: Ophthalmic Drugs Development Pipeline
15.9.3 Senju: Sales Forecast, 2020-2030
15.9.4 Senju: Recent Developments
15.10 Bausch Health Companies Inc.
15.10.1 Bausch Health Companies Inc.: Ophthalmic Drugs Portfolio
15.10.2 Bausch Health Companies Inc. AG: Financial Overview
15.10.3 Bausch Health: Sales Forecast, 2020-2030
15.10.4 Bausch Health Companies Inc: Ophthalmic Drugs Development Pipeline
15.10.5 Bausch Health Companies Inc.: Recent Developments
15.11 Akorn, Inc.
15.11.1 Akorn, Inc.: Ophthalmic Drugs Portfolio
15.11.2 Akorn, Inc. AG: Financial Overview
15.11.3 Akorn, Inc.: Sales Forecast, 2020-2030
15.11.4 Akorn, Inc.: Recent Developments
15.12 Sun Pharmaceutical Industries Ltd.
15.12.1 Sun Pharmaceutical Industries Ltd.: Ophthalmic Drugs Portfolio
15.12.2 Sun Pharmaceutical Industries Ltd. AG: Financial Overview
15.12.3 Sun Pharmaceutical: Ophthalmic Drugs Development Pipeline
15.12.4 Sun Pharmaceutical Industries Ltd. : Recent Developments
15.13 Aerie Pharmaceuticals Inc
15.13.1 Aerie Pharmaceuticals Inc.: Ophthalmic Drugs Portfolio
15.13.2 Aerie Pharmaceuticals Inc. AG: Financial Overview
15.13.3 Aerie Pharmaceuticals: Ophthalmic Drugs Development Pipeline
15.13.4 Aerie Pharmaceuticals Inc.: Recent Developments
15.14 Biogen
15.14.1 Biogen Inc.: Ophthalmic Drugs Portfolio
15.14.2 Biogen AG: Financial Overview
15.14.3 Biogen: Recent Developments
16. Ophthalmic Drugs: Research and Development Pipeline, 2020-2030
16.1 The Ophthalmic Drugs Pipeline: Intensive Development Efforts in Retinal Disorders
16.2 Drugs for Retinal Disorders: Development Pipeline
16.2.1 Will Bevasiranib (RXi Pharmaceuticals) Resume Development?
16.3 Retinal Disorders: Filed or Recently Launched
16.3.1 Beovu (brolucizumab) – Novartis
16.3.3 CompaqSipp (conbercept) – Chengdu Kanghong Pharmaceutical
16.3.3 Lipidil (fenofibrate) - Abbott
16.3.4 luvien (fluocinolone) – Alimera Sciences
16.4 Drugs in Phase 3 Development for Retinal Disorders
16.4.1 AGN150998 and MP0260 (Anti-VEGFDARPins) - Allergan
16.4.2 Fovista and Zimura – Ophthotech Corporation
16.4.3 Lampalizumab (anti-FactorD Fab) - Roche
16.4.4 MC-1101 (hydralazine) – Macu CLEAR
16.4.5 Squalamine (anti-angiogenic drug) - OHRPharmaceutical
16.4.6 Tandospirone (serotonin 1A agonist) – Alcon (Novartis)
16.4.7 UF-021 (unoprostone) - R-TechUeno
16.5 Drugs in Phase 2 Development for Retinal Disorders
16.5.1 AKB-9778 (Tie2 activator) - AerpioTherapeutics
16.5.2 Luminate (ALG-1001; Integrin peptide therapy) - Allegro/Senju
16.5.3 AGN208397 (beclomethasone) - Allergan
16.5.4 CPC 551 - Colby Pharmaceutical
16.5.5 ESBA1008 (anti-VEGF mAb) – Alcon (Novartis)
16.5.6 iCo-007 (antisense inhibitor of C-raf kinase mRNA) - iCo Therapeutics
16.5.7 LFG316 (anti-C5 mAb) - Novartis
16.5.8 Intravitreal brimonidine implant - Allergan
16.5.9 Optina (danazol) – Ampio Pharmaceuticals
16.5.10 PF-655 (synthetic siRNA) - Quark/Pfizer
16.5.11 Premiplex (SHP-607) - Shire
16.5.12 Renexus (ciliary neurotrophic factor) - Neurotech
16.5.13 Zybrestat (fosbretabulin) - Oxigene/Symphony VIDA
16.6 Drugs in Phase 1 and Pre-Clinical Development for Retinal Disorders
16.6.1 BDM-E - BioDiem
16.6.2 NADPHOxidaseInhibitors – AlimeraSciences
16.6.3 PAN-90806 (topical VEGF inhibitor) - PanOptica
16.6.5 QLT091001 (synthetic retinoid) – QLT
16.6.4 PlasmaKallikreinInhibitors (KVD001) - KalVista
16.7 Drugs in Phase 3 Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.7.1 EGP-437 (dexamethasone) – EyeGate Pharmaceuticals
16.7.2 IBI-10090 and IBI-20089 - Icon Bioscience
16.7.3 KPI-121 (loteprednol etabonate) - Kala
16.8 Drugs in Phase 2 Development for Allergic, Inflammatory And Infective Ophthalmic Conditions
16.8.1 CF101 (adenosine A3 receptor agonist) - Can-Fite BioPharma and OphthaliX
16.8.2 FST-100 (povidone-iodine/dexamethasone) - Shire
16.8.3 NVC-422 (auriclosene) - NovaBay
16.8.4 Sarilumab - Regeneron
16.9 Drugs in Phase 1 and Pre-Clinical Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.9.1 Finafloxacin – MerLion Pharmaceuticals/Novartis
16.10 Drugs for Glaucoma: Development Pipeline, 2020
16.10.1 Drugs in Phase 1 and Pre-Clinical Development for Glaucoma
16.11 Drugs in Phase 3 Development for Dry Eye
16.11.1 EBI-005 (IL-1R antagonist) – Eleven Bio therapeutics
16.11.2 Lifitegrast (integrin antagonist) - Shire
16.11.3 Tavilermide (formerly MIM-D3tyrosine kinase receptor antagonist) - Allergan
16.11.1 SI-614 (modified hyaluronate)-Siekagaku
16.12. Drugs in Phase 2 Development for Dry Eye
16.12.1 ESBA105 (TNF-alpha antibody) - Alcon (Novartis)
16.12.2 Kineret (anakinra: IL-1 receptor antagonist) - Amgen/Sobi
16.13 Other Drugs in the Development Pipeline for Ophthalmic Conditions
16.13.1 Brimonidine for Eye Whitening - Valeant
16.13.2 GS-101 (aganirsen) - GeneSignal
16.13.3 Omidria (phenylephrine/ketorolac) - Omeros
17. Conclusions
17.1 Overview of Current Market Conditions and Market Forecast, 2020-2030
17.3 Leading Regions in the Ophthalmic Drugs Market in 2020
17.4 Leading Companies in the Ophthalmic Drugs Market, 2020
17.5 What Does the Future Hold for Ophthalmic Drugs?
List of Tables
Table 1 Report Summary
Table 2 ICD-10 Classification of Visual Impairment, 2017
Table 3 Classification of Glaucoma
Table 4 Drug Treatments for AMD, 2020
Table 5 Drug Treatments for Ocular Allergy, 2020
Table 6 Drug Treatments for Ocular Inflammatory Disease, 2020
Table 7 Selected Drug Treatments for Eye Infections, 2020
Table 8 Clinical Trial Phases
Table 9 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 10 World 65+ Population Forecast: Size (m), AGR (%), 2017-2028
Table 11 Global Prevalence Forecast for Ophthalmic Diseases
Table 12 PESTEL Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 13 Global Ophthalmic Drugs Market Snapshot, 2020 & 2030 (US$ Mn, CAGR %)
Table 14 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 15 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 16 Pre-Covid Global ophthalmic drugs market by Indication: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 17 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 18 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 19 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 20 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 21 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 22 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 23 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 24 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 25 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 26 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 27 Pre-Covid Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 28 V-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 29 U-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 30 L-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 31 W-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 32 Pre-Covid Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 33 V-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 34 U-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 35 L-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 36 W-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 37 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 38 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 39 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 40 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 41 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 42 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 43 Pre-Covid Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 44 V-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 45 U-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 46 L-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 47 W-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 48 Pre-Covid Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 49 V-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 50 U-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 51 L-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 52 W-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 53 Pre-Covid Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 54 V-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 55 U-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 56 L-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 57 W-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 58 Global Retinal Disorder Drugs Market by Drugs, 2020
Table 59 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 60 V-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 61 U-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 62 L-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 63 W-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 64 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 65 Global Retinal Disorder Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 66 V-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 67 U-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 68 L-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 69 W-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 70 Global Eylea market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 71 Global Lucentis market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 72 Global Avastin market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 73 Global Visudyne market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 74 Global Jetrea market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 75 Global BEOVU market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 76 Global Allergic, Inflammatory & Infective Drugs Market by Drugs, 2020
Table 77 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 78 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 79 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 80 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 81 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 82 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 83 Global Allergic, Inflammatory & Infective Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 84 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 85 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 86 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 87 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 88 Global Pataday market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 89 Global Patanol market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 90 Global Vigamox market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 91 Global TobraDex market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 92 Global Cravit market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 93 Global Acular market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 94 Global AzaSite market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 95 Global Bromday market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 96 Global Glaucoma Drugs Market by Drugs, 2019
Table 97 Pre-Covid Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 98 V-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 99 U-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 100 L-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 101 W-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 102 Pre-Covid Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 103 Global Glaucoma Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 104 V-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 105 U-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 106 L-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 107 W-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 108 Global Lumigan & Ganfort market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 109 Global Travatan & Duotrav market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 110 Global Alphagan & Combigan market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 111 Global Xalatan & Xalacom market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 112 Global Azopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 113 Global Cosopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 114 Global Tapros market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 115 Global Trusopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 116 Global Zioptan market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 117 Global Rhopressa market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 118 Global Dry Eye Drugs Market by Drugs, 2019
Table 119 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 120 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 121 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 122 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 123 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 124 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 125 Global Dry Eye Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 126 Global Restasis market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 127 Global Refresh market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 128 Global Hyalein market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 129 Global Diquas market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 130 Global Artelac market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 131 Global others dry eye drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 132 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 133 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 134 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 135 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 136 Global Ophthalmic Drugs Market by Region, By Revenue ($mn) and Market Share (%), 2020
Table 137 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 138 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 139 Global ophthalmic drugs market by Region: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 140 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 141 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 142 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 143 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 144 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 145 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 146 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 147 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 148 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 149 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 150 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 151 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 152 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 153 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 154 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 155 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 156 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 157 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 158 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 159 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 160 North America ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 161 U.S. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 162 Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 163 V-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 164 V-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 165 U-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 166 U-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 167 L-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 168 L-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 169 W-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 170 W-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 171 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 172 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 173 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 174 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 175 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 176 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 177 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 178 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 179 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 180 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 181 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 182 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 183 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 184 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 185 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 186 Pre-Covid Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 187 Europe ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 188 Germany Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 189 France Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 190 U.K. Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 191 Italy Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 192 Spain Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 193 Russia Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 194 Poland Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 195 Rest of Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 196 V-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 197 V-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 198 V-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 199 V-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 200 V-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 201 V-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 202 V-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 203 V-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 204 V-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 205 U-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 206 U-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 207 U-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 208 U-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 209 U-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 210 U-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 211 U-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 212 U-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 213 U-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 214 L-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 215 L-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 216 L-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 217 L-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 218 L-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 219 L-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 220 L-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 221 L-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 222 L-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 223 W-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 224 W-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 225 W-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 226 W-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 227 W-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 228 W-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 229 W-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 230 W-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 231 W-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 232 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 233 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 234 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 235 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 236 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 237 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 238 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 239 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 240 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 241 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 242 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 243 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 244 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 245 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 246 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 247 Pre-Covid Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 248 Asia Pacific ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 249 China Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 250 Japan Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 251 India Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 252 Australia Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 253 South Korea Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 254 Rest of Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 255 V-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 256 V-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 257 V-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 258 V-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 259 V-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 260 V-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 261 V-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 262 U-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 263 U-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 264 U-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 265 U-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 266 U-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 267 U-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 268 U-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 269 L-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 270 L-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 271 L-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 272 L-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 273 L-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 274 L-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 275 L-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 276 W-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 277 W-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 278 W-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 279 W-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 280 W-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 281 W-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 282 W-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 283 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 284 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 285 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 286 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 287 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 288 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 289 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 290 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 291 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 292 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 293 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 294 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 295 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 296 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 297 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 298 Pre-Covid Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 299 Latin America ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 300 Brazil Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 301 Mexico Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 302 Rest of Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 303 V-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 304 V-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 305 V-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 306 V-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 307 U-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 308 U-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 309 U-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 310 U-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 311 L-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 312 L-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 313 L-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 314 L-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 315 W-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 316 W-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 317 W-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 318 W-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 319 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 320 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 321 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 322 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 323 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 324 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 325 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 326 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 327 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 328 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 329 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 330 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 331 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 332 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 333 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 334 Pre-Covid Middle East & Africa Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 335 Middle East & Africa ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 336 V-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 337 V-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 338 V-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 339 V-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 340 V-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 341 U-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 342 U-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 343 U-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 344 U-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 345 U-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 346 L-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 347 L-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 348 L-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 349 L-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 350 L-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 351 W-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 352 W-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 353 W-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 354 W-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 355 W-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 356 Pre-Covid Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
Table 357 Novartis: Overview, 2020
Table 358 Novartis AG: Revenue ($m), AGR (%), 2015-2019
Table 359 Novartis: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 360 Regeneron: Overview, 2020
Table 361 Regeneron: Revenue ($m), AGR (%), 2015-2019
Table 362 Regeneron: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 363 Allergan: Overview, 2020
Table 364 Allergan: Revenue ($m), AGR (%), 2015-2019
Table 365 Allergan: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 366 Roche: Overview, 2020
Table 367 Roche: Revenue ($m), AGR (%), 2015-2019
Table 368 Roche: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 369 Santen: Overview, 2020
Table 370 Santen: Revenue ($m), AGR (%), 2015-2019
Table 371 Santen: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 372 Bayer: Overview, 2020
Table 373 Bayer: Revenue ($m), AGR (%), 2015-2019
Table 374 Bayer: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 375 Pfizer: Overview, 2020
Table 376 Pfizer: Revenue ($m), AGR (%), 2015-2019
Table 377 Pfizer: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 378 Senju: Overview, 2020
Table 379 Senju: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 380 Bausch Health Companies Inc. : Overview, 2020
Table 381 Bausch Health Companies Inc. AG: Revenue ($m), AGR (%), 2015-2019
Table 382 Bausch Health: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 383 Akorn, Inc. : Overview, 2020
Table 384 Akorn, Inc. AG: Revenue ($m), AGR (%), 2015-2019
Table 385 Akorn, Inc.: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 386 Sun Pharmaceutical Industries Ltd. : Overview, 2020
Table 387 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), AGR (%), 2015-2019
Table 388 Aerie Pharmaceuticals Inc : Overview, 2020
Table 389 Aerie Pharmaceuticals Inc AG: Revenue ($m), AGR (%), 2015-2019
Table 390 Biogen : Overview, 2020
Table 391 Biogen AG: Revenue ($m), AGR (%), 2015-2019
Table 392 Retinal Disorders Drugs Pipeline: Phase 3 Drugs
Table 393 Retinal Disorders Drugs Pipeline: Phase 2 Drugs
Table 394 Retinal Disorders Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 395 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 3 Drugs
Table 396 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 2 Drugs
Table 397 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 398 Glaucoma Drugs Pipeline: Phase 2&3 Drugs
Table 399 Glaucoma Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 400 Dry Eye Drugs Pipeline: Phase 3 Drugs
Table 401 Dry Eye Drugs Pipeline: Phase 2 Drugs
Table 402 Other Pipeline Products for Ophthalmic Conditions
Table 403 Global Ophthalmic Drugs Market by Indication, 2019
Table 404 Global Ophthalmic Drugs Market by Region, 2020
Table 405 Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
List of Figures
Figure 1 Global Ophthalmic Drugs Market: Market Sectors, 2020
Figure 2 Structure of The Human Eye
Figure 3 Estimated Global Blindness and Visual Impairment (% of people), 2017
Figure 4 Global Causes of Visual Impairment (Million Cases)
Figure 5 Global Estimates of Numbers of People Affected by Selected Eye Conditions that Can Cause Vision Impairment (Million Cases)
Figure 6 Classification of Glaucoma
Figure 7 World 65+ Population Forecast: Size (m), AGR (%), 2017-2028
Figure 8 Global Prevalence of Diabetes and Diabetic Retinopathy, 2010 and 2030
Figure 9 Porter’s Five Force Analysis of the Ophthalmic Drugs Market, 2019
Figure 10 Global ophthalmic drugs market share, by indication, 2020 & 2030
Figure 11 Pre-Covid Global Ophthalmic Drugs Market, 2020-2030 ($m, AGR %)
Figure 12 Pre-Covid Global ophthalmic drugs market forecast by indication, 20 20
Figure 13 Pre-Covid Global ophthalmic drugs market forecast by indication, 2025
Figure 14 Pre-Covid Global ophthalmic drugs market forecast by indication, 2030
Figure 15 V-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 16 U-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 17 L-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 18 W-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 19 Global ophthalmic drugs market share, by type, 2020 & 2030
Figure 20 Global ophthalmic drugs market forecast (US$ Mn) by type, 20 20
Figure 21 Global ophthalmic drugs market (US$ Mn) forecast by type, 202 5
Figure 22 Global ophthalmic drugs market (US$ Mn) forecast by type, 2030
Figure 23 V-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 24 U-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 25 L-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 26 W-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 27 Pre-Covid Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 28 V-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 29 U-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 30 L-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 31 W-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 32 Pre-Covid Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 33 V-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 34 U-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 35 L-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 36 W-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 37 Global ophthalmic drugs market share, by type, 2020 & 2030
Figure 38 Global ophthalmic drugs market (US$ Mn) forecast by type, 20 20
Figure 39 Global ophthalmic drugs market (US$ Mn) forecast by type, 202 5
Figure 40 Global ophthalmic drugs market (US$ Mn) forecast by type, 2030
Figure 41 Pre-Covid Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 42 V-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 43 U-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 44 L-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 45 W-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 46 Pre-Covid Global drug stores market, 2020-2030 ($m, AGR%)
Figure 47 V-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 48 U-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 49 L-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 50 W-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 51 Pre-Covid Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 52 V-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 53 U-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 54 L-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 55 W-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 56 Global Retinal Disorder Drugs market share, by Drugs, 2020 & 2030
Figure 57 Pre-Covid Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 58 V-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 59 U-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 60 L-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 61 W-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 62 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 2020
Figure 63 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 202 5
Figure 64 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 2030
Figure 65 Global Eylea market, 2020-2030 ($m, AGR%)
Figure 66 Global Lucentis market, 2020-2030 ($m, AGR%)
Figure 67 Global Avastin market, 2020-2030 ($m, AGR%)
Figure 68 Global Visudyne market, 2020-2030 ($m, AGR %)
Figure 69 Global Jetrea market, 2020-2030 ($m, AGR %)
Figure 70 Global BEOVU market, 2020-2030 ($m, AGR%)
Figure 71 Global Allergic, Inflammatory & Infective Drugs market share, by Drugs, 2020 & 2030
Figure 72 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR %)
Figure 73 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 74 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 75 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 76 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 77 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2020
Figure 78 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2025
Figure 79 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2030
Figure 80 Global Pataday market, 2020-2030 ($m, AGR%)
Figure 81 Global Patanol market, 2020-2030 ($m, AGR%)
Figure 82 Global Vigamox market, 2020-2030 ($m, AGR%)
Figure 83 Global TobraDex market, 2020-2030 ($m, AGR%)
Figure 84 Global Cravit market, 2020-2030 ($m, AGR%)
Figure 85 Global Acular market, 2020-2030 ($m, AGR%)
Figure 86 Global AzaSite market, 2020-2030 ($m, AGR%)
Figure 87 Global Bromday market, 2020-2030 ($m, AGR%)
Figure 88 Global Glaucoma Drugs market share, by Drugs, 2020 & 2030
Figure 89 Pre-Covid Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 90 V-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 91 U-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 92 L-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 93 W-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 94 Global Glaucoma Drugs market forecast by Drugs, 2020
Figure 95 Global Glaucoma Drugs market forecast by Drugs, 2025
Figure 96 Global Glaucoma Drugs market forecast by Drugs, 2030
Figure 97 Global Lumigan & Ganfort market, 2020-2030 ($m, AGR%)
Figure 98 Global Travatan & Duotrav market, 2020-2030 ($m, AGR%)
Figure 99 Global Alphagan & Combigan market, 2020-2030 ($m, AGR%)
Figure 100 Global Xalatan & Xalacom market, 2020-2030 ($m, AGR%)
Figure 101 Global Azopt market, 2020-2030 ($m, AGR%)
Figure 102 Global Cosopt market, 2020-2030 ($m, AGR%)
Figure 103 Global Tapros market, 2020-2030 ($m, AGR%)
Figure 104 Global Trusopt market, 2020-2030 ($m, AGR%)
Figure 105 Global Zioptan market, 2020-2030 ($m, AGR%)
Figure 106 Global Rhopressa market, 2020-2030 ($m, AGR%)
Figure 107 Pre-Covid Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 108 V-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 109 U-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 110 L-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 111 W-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 112 Global Dry Eye Drugs market forecast by Drugs, 2020
Figure 113 Global Dry Eye Drugs market forecast by Drugs, 2025
Figure 114 Global Dry Eye Drugs market forecast by Drugs, 2030
Figure 115 Global Restasis market, 2020-2030 ($m, AGR%)
Figure 116 Global Refresh market, 2020-2030 ($m, AGR%)
Figure 117 Global Hyalein market, 2020-2030 ($m, AGR%)
Figure 118 Global Diquas market, 2020-2030 ($m, AGR%)
Figure 119 Global Artelac market, 2020-2030 ($m, AGR%)
Figure 120 Global others dry eye drugs market, 2020-2030 ($m, AGR%)
Figure 121 V-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 122 U-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 123 L-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 124 W-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 125 Global ophthalmic drugs market share, by Region, 20 20 & 2030
Figure 126 Pre-Covid Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 127 Global ophthalmic drugs market forecast by Region, 2020
Figure 128 Global ophthalmic drugs market forecast by Region, 2025
Figure 129 Global ophthalmic drugs market forecast by Region, 2030
Figure 130 Pre-Covid North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 131 V-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 132 U-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 133 L-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 134 W-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 135 North America ophthalmic drugs market share, by country, 2020 & 2030
Figure 136 North America ophthalmic drugs market forecast by Country, 2020
Figure 137 North America ophthalmic drugs market forecast by Country, 2025
Figure 138 North America ophthalmic drugs market forecast by Country, 2030
Figure 139 U.S ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 140 Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 141 V-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 142 V-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 143 U-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 144 V-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 145 L-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 146 L-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 147 W-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 148 W-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 149 Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 150 V-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 151 U-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 152 L-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR %)
Figure 153 W-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 154 Europe ophthalmic drugs market share, by country, 2020 & 2030
Figure 155 Europe ophthalmic drugs market forecast by country, 2020
Figure 156 Europe ophthalmic drugs market forecast by country, 2025
Figure 157 Europe ophthalmic drugs market forecast by country, 2030
Figure 158 Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 159 France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 160 U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 161 Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 162 Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 163 Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 164 Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 165 Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 166 V-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 167 V-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 168 V-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 169 V-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 170 V-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 171 V-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 172 V-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 173 V-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 174 U-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 175 U-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 176 U-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 177 U-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 178 U-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 179 U-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 180 U-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 181 U-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 182 L-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 183 L-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 184 L-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 185 L-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 186 L-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 187 L-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 188 L-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 189 L-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 190 W-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 191 W-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 192 W-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 193 W-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 194 W-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Figure 195 W-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 196 W-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 197 W-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 198 Proportion of population aged 80 or older among the population aged 60 or older, by country or territory in East and North-East Asia, 1970–2050
Figure 199 Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 200 V-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 201 U-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 202 L-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 203 W-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 204 Asia Pacific ophthalmic drugs market share, by country, 2020 & 2030
Figure 205 Asia Pacific ophthalmic drugs market forecast by country, 2020
Figure 206 Asia Pacific ophthalmic drugs market forecast by country, 2025
Figure 207 Asia Pacific ophthalmic drugs market forecast by country, 2030
Figure 208 V-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 209 V-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 210 V-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 211 V-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 212 V-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 213 V-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 214 U-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 215 U-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 216 U-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 217 U-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 218 U-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 219 U-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 220 L-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 221 L-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 222 L-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 223 L-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 224 L-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 225 L-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 226 W-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 227 W-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 228 W-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 229 W-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 230 W-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Figure 231 W-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 232 Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 233 V-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 234 U-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 235 L-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 236 W-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 237 Latin America ophthalmic drugs market share, by country, 2020 & 2030
Figure 238 Latin America ophthalmic drugs market forecast by type, 2025
Figure 239 Latin America ophthalmic drugs market forecast by type, 2030
Figure 240 Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 241 Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 242 Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 243 V-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 244 V-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 245 V-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 246 U-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 247 U-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 248 U-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 249 L-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 250 L-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 251 L-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 252 W-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 253 W-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 254 W-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 255 Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 256 V-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR %)
Figure 257 U-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 258 L-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 259 W-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 260 Middle East & Africa ophthalmic drugs market share, by country, 20 20 & 2030
Figure 261 Middle East & Africa ophthalmic drugs market forecast by type, 2020
Figure 262 Middle East & Africa ophthalmic drugs market forecast by type, 2025
Figure 263 Middle East & Africa ophthalmic drugs market forecast by type, 2030
Figure 264 Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 265 South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 266 UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 267 Rest of Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 268 V-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 269 V-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 270 V-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 271 V-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 272 U-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 273 U-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 274 U-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 275 U-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 276 L-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 277 L-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 278 L-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 279 L-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 280 W-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 281 W-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 282 W-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 283 W-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 284 Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
Figure 285 Novartis AG: Revenue ($m), 2015-2019
Figure 286 Novartis AG: Revenue ($m), By Segment, 2019
Figure 287 Novartis AG: Revenue ($m), By Region, 2019
Figure 288 Novartis: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 289 Regeneron: Revenue ($m), 2015-2019
Figure 290 Regeneron: Revenue ($m), By Segment, 2019
Figure 291 Regeneron: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 292 Allergan: Revenue ($m), 2015-2019
Figure 293 Allergan: Revenue ($m), By Product, 2019
Figure 294 Allergan: Revenue ($m), By Segment, 2019
Figure 295 Allergan: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 296 Roche: Revenue ($m), 2015-2019
Figure 297 Roche: Revenue ($m), By Division, 2019
Figure 298 Roche: Revenue ($m), By Region, 2019
Figure 299 Roche: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 300 Santen: Revenue ($m), 2015-2019
Figure 301 Santen: Revenue ($m), By Region, 2019
Figure 302 Santen: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 303 Bayer: Revenue ($m), 2015-2019
Figure 304 Bayer: Revenue ($m), By Division, 2019
Figure 305 Bayer: Revenue ($m), By Region, 2019
Figure 306 Bayer: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 307 Pfizer: Revenue ($m), 2015-2019
Figure 308 Pfizer: Revenue ($m), By Segment, 2019
Figure 309 Pfizer: Revenue ($m), By Region, 2019
Figure 310 Pfizer: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 311 Senju: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 312 Bausch Health Companies Inc. AG: Revenue ($m), 2015-2019
Figure 313 Bausch Health Companies Inc. AG: Revenue ($m), By Segment, 2019
Figure 314 Bausch Health Companies Inc. AG: Revenue ($m), By Region, 2019
Figure 315 Bausch Health: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 316 Akorn, Inc. AG: Revenue ($m), 2015-2019
Figure 317 Akorn, Inc. AG: Revenue ($m), By Segment, 2019
Figure 318 Akorn, Inc. AG: Revenue ($m), By Customer, 2019
Figure 319 Akorn, Inc.: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 320 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), 2015-2019
Figure 321 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), By Segment, 2019
Figure 322 Aerie Pharmaceuticals Inc AG: Revenue ($m, % AGR), 2015-2019
Figure 323 Biogen AG: Revenue ($m), 2015-2019
Figure 324 Biogen AG: Revenue ($m), By Segment, 2019
Figure 325 Biogen AG: Revenue ($m), By Region, 2019
Figure 326 Global ophthalmic drugs market, 2020-2030 ($m, % AGR)
Figure 327 Global ophthalmic drugs market share, by indication, 2020 & 2030
Figure 328 Global ophthalmic drugs market share, by Region, 2020 & 2030
1.1 Global Ophthalmic Drugs Market Overview
1.2 Global Ophthalmic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Ophthalmic Drugs
2.1. The Pharmaceutical Industry: Very Brief Overview
2.2 Structure and Function of the Eyes
2.3 The Global Burden of Eye Disease
2.4 Vision Impairment
2.5 Ophthalmic Drugs: Market Segmentation
2.6 Glaucoma: A Major Cause of Vision Loss
2.6.1 A Classification of Glaucoma
2.6.2 Primary Open-Angle Glaucoma
2.6.3 Acute Angle-Closure Glaucoma
2.6.4 Congenital Glaucoma
2.6.5 Secondary Glaucoma
2.6.6 Normal-Tension Glaucoma
2.6.7 Ocular Hypertension
2.7 Risk Factors for Glaucoma
2.8 Diagnosis of Glaucoma
2.9 Drug Treatment of Glaucoma
2.10 Laser Treatment and Surgery for Glaucoma
2.11 Age-Related Macular Degeneration (AMD)
2.11.1 Dry (non-exudative) AMD
2.11.2 Wet (exudative) AMD
2.11.3 Risk Factors for AMD
2.11.4 Diagnosis of AMD
2.11.5 Treatment of AMD
2.12 Diabetic Retinopathy (DR)
2.12.1 Diagnosis of Diabetic Retinopathy
2.12.2 Treatment of Diabetic Retinopathy
2.13 Ocular Allergy and Allergic Conjunctivitis
2.13.1 Diagnosis of Ocular Allergy
2.13.2 Treatment of Ocular Allergy
2.14 Ocular Inflammatory Disease
2.14.1 Treatment of Ocular Inflammatory Disease
2.15 Eye Infections
2.15.1 Treatment of Eye Infections
2.16 Dry Eye Syndrome
2.16.1 Treatment of Dry Eye Syndrome
2.17 Phases of Clinical Trials
2.18 Impact of Covid-19 on Ophthalmic Drugs Market
3. Qualitative Analysis of the Ophthalmic Drugs Market, 2020-2030
3.1 Market Factors Influencing Ophthalmic Drugs
3.2 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
3.2.1 Strengths
3.2.1.1 Strengths Healthy R&D Pipeline
3.2.1.2 Advances in Drug Delivery Technologies
3.2.1.3 Support for Reimbursement and Payment Approvals
3.2.1.4 Gene Therapy and RNAi Technology
3.2.1.5 New Ophthalmic Therapeutic Applications for Drugs
3.2.1.6 Development of Neuroprotective Anti-Glaucoma Medications
3.2.1.7 Biomarkers as Tools for Better Diagnosis and Treatment
3.2.2 Weaknesses
3.2.2.1 Low Levels of Patient Adherence to Treatment
3.2.2.2 High Treatment Burden on Patients and Healthcare Providers
3.2.2.3 Under-Diagnosis and Under-Treatment
3.2.3 Opportunities
3.2.3.1 Sustained-Release Ocular Implants
3.2.3.2 The Impact of a Rapidly Ageing Global Population
3.2.3.3 Increasing Prevalence of Diabetes and Ocular Disease
3.2.3.4 Glaucoma and Retinal Disorders Set for Most-Marked Increases in Prevalence
3.2.3.5 Unmet Clinical Need in Many Disease Areas
3.2.3.6 Economic Growth in Emerging Market Provide Opportunity for Expansion
3.2.4 Threats
3.2.4.1 Intensifying Price Regulation in The Market
3.2.4.2 Generic Competition – Likely to Cause Erosion of Sales for Market Leading Brands
3.2.4.3 Rising Cost Of R&D
3.2.4.4 Biosimilars – A Bigger Threat than Generics?
3.3 Porter’s Five Force Analysis of The Global Ophthalmic Drugs Market, 2020-2029
3.3.1 Threat of New Entrants
3.3.2 Rivalry Among Competitors
3.3.3 Power of Suppliers
3.3.5 Power of Buyers
3.3.5 Power of Buyers
3.4. PESTEL Analysis
4. Ophthalmic Drugs Market, 2020-2030
4.1 Global Ophthalmic Drugs Market Overview
4.2 Categorizations of the Global Ophthalmic Drugs Market
4.3 Global Ophthalmic Drugs Market Overview
4.4 Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
4.5 Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6 Global Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
4.6.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.6 Pre-Covid Prescription Drugs: Revenue Forecast, 2020-2030
4.6.7 V-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.8 U-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.9 L-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.10 W-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.11 Pre-Covid OTC Drugs: Revenue Forecast, 2020-2030
4.6.12 V-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.13 U-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.14 L-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.15 W-Shaped RecoveryOTC Drugs: Revenue Forecast, 2020-2030
4.7 Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.1 Pre-Covid Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.6 Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.1 Pre-Covid Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.2 V-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.3 U-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.4 L-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.5 W-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.7 Drug Stores: Revenue Forecast, 2020-2030
4.7.7.1 Pre-Covid Drug Stores: Revenue Forecast, 2020-2030
4.7.7.2 V-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.3 U-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.4 L-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.5 W-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.8 Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.1 Pre-Covid Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.2 V-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.3 U-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.4 L-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.5 W-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.8 Covid-19 Impact on Ophthalmic Drugs Market
5. Retinal Disorder Drugs Market, 2020-2030
5.1 Global Retinal Disorder Drugs Market Overview
5.2 Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.1 Pre-Covid Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.2 V-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.3 U-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.4 L-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.5 W-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.3 Trend of Retinal Diseases in Developing Countries
5.4 Has Monotherapy Reached Its Limit?
5.5 Technologies that could transform the treatment of blindness
5.5.1 How Likely Is Avastin’s Expansion into Age-Related Macular Degeneration?
5.6 Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.6.1 Pre-Covid Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.7. Eylea (aflibercept) - Regeneron/ Bayer/ Santen: Revenue Forecast, 2020-2030
5.7.1 Eylea/Zaltrap and the Davis-Smyth Patent Agreements
5.7.2 Possible Combination Therapies Involving Eylea
5.8 Lucentis (ranibizumab) – Roche/ Novartis: Revenue Forecast, 2020-2030
5.8.1 Lucentis Approvals for New Indications
5.9 Avastin (bevacizumab) - Roche: Revenue Forecast, 2020-2030
5.9.1 Very low-dose Avastin may help prevent retinopathy of prematurity
5.9.2 Avastin Repackages Must Meet New Guidance
5.10 Visudyne (verteporfin) - Valeant/ Novartis: Revenue Forecast, 2020-2030
5.11 Jetrea (ocriplasmin) - ThromboGenics/ Novartis: Revenue Forecast, 2020-2030
5.12 BEOVU (brolucizumab-dbll): Revenue Forecast, 2020-2030
5.13 Other Retinal Disorder Drugs
5.13.1 Iluvien (fluocinolone implant) - Alimera Sciences
5.13.2 Ozurdex (dexamethasone implant) – Allergan
5.14 Covid-19 Impact on Retinal Disorder Drugs Market
5.15.1 V-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.2 U-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.3 L-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.15.4 W-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
6. Allergic, Inflammatory & Infective Drugs Market, 2020-2030
6.1 Global Allergic, Inflammatory & Infective Drugs Market Overview
6.2 Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.1 Pre-Covid Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.2 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.3 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.4 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.5 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.3 Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.4 Patanol And Pataday (olopatadine) - Alcon (Novartis)
6.4.1 Pataday: Revenue Forecast, 2020-2030
6.4.2 Patanol: Revenue Forecast, 2020-2030
6.4.3 Approval of Pazeo Solution
6.5 Vigamox (moxifloxacin) – Alcon (Novartis): Revenue Forecast, 2020-2030
6.5.1 Intensifying Competition and Generics Drug Challenge to Vigamox
6.6 TobraDex (tobramycin/dexamethasone) - Eyevance Pharmaceuticals: Revenue Forecast, 2020-2030
6.7 Cravit (levofloxacin) - Santen: Revenue Forecast, 2020-2030
6.8 Acular (ketorolac) – Allergan: Revenue Forecast, 2020-2030
6.9 AzaSite (azithromycin): Revenue Forecast, 2020-2030
6.10 Bromday (bromfenac): Revenue Forecast, 2020-2030
6.11 Covid-19 Impact on Allergic, Inflammatory & Infective Drugs Market
6.11.1 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.2 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.3 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.4 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
7. Glaucoma Drugs Market, 2020-2030
7.1 Global Glaucoma Drugs Market Overview
7.2 Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.1 Pre-Covid Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.2 V-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.3 U-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.4 L-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.5 W-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.3 Pre-Covid Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.4 Glaucoma Drugs: Market Trends and Developments, 2020
7.4.1 Patent Expiration: A Major Restraint for Glaucoma Drugs
7.4.2 Innovation in Glaucoma Management
7.5 Lumigan & Ganfort (bimatoprost) – Allergan (Actavis): Revenue Forecast, 2020-2030
7.6 Travatan/Travatan Z & Duotrav (travoprost) - Novartis: Revenue Forecast, 2020-2030
7.7 Alphagan & Combigan: Revenue Forecast, 2020-2030
7.8 Xalatan & Xalacom (latanoprost) - Pfizer: Revenue Forecast, 2020-2030
7.9 Azopt (brinzolamide) - Novartis: Revenue Forecast, 2020-2030
7.10 Cosopt/ Cosopt PF: Revenue Forecast, 2020-2030
7.11 Tapros (tafluprost) – Santen: Revenue Forecast, 2020-2030
7.12 Trusopt: Revenue Forecast, 2020-2030
7.13 Zioptan (Tafluprost): Revenue Forecast, 2020-2030
7.14 Rhopressa (netarsudil): Revenue Forecast, 2020-2030
7.15 Covid-19 Impact on Glaucoma Drugs Market
7.15.1 V-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.2 U-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.3 L-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.4 W-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
8. Dry Eye Drugs Market, 2020-2030
8.1 Global Dry Eye Drugs Market Overview
8.2 Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.1 Pre-Covid Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.2 V-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.3 U-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.4 L-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.5 W-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.3 Pre-Covid Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.4 Dry Eye Drugs: Market Trends and Developments, 2020
8.4.1 Restasis: Patent Elongations and Generic Challenges Creating Uncertainty
8.4.2 Concept of new dry eye diagnosis: tear film-oriented diagnosis
8.5 Restasis: Revenue Forecast, 2020-2030
8.6 Refresh: Revenue Forecast, 2020-2030
8.7 Hyalein: Revenue Forecast, 2020-2030
8.8 Diquas: Revenue Forecast, 2020-2030
8.9 Artelac (Hypromellose) - Bausch + Lomb: Revenue Forecast, 2020-2030
8.10 Others Dry Eye Drugs: Revenue Forecast, 2020-2030
8.11 Covid-19 Impact on Dry Eye Drugs Market
8.11.1 V-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.2 U-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.3 L-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.4 W-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
9. Ophthalmic Drugs Market, 2020-2030, By Region
9.1 Global Ophthalmic Drugs Market Overview
9.2 Pre-Covid Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
9.3 Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.1 Pre-Covid Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
10. North America Ophthalmic Drugs Market, 2020-2030
10.1 North America Ophthalmic Drugs Market Overview
10.2 North America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
10.3 North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.1 Pre-Covid North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.4 North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.1 Pre-Covid North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.5 North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.1 Pre-Covid North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.6 North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.1 Pre-Covid North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.2 U.S. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
10.6.2.1 Is there a big change around the corner?
10.6.3 Canada Ophthalmic Drugs: Revenue Forecast, 2020-2030
10.7 Covid-19 Impact on North America Ophthalmic Drugs Market
10.7.1 V-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.1.1 V-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.1.2 V-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2 U-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.2.1 U-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2.2 U-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3 L-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.3.1 L-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3.2 L-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4 W-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.4.1 W-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4.2 W-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
11. Europe Ophthalmic Drugs Market, 2020-2030
11.1 Europe Ophthalmic Drugs Market Overview
11.2 Europe Ophthalmic Drugs Market: Revenue Forecast 2020-2030
11.3 Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.1 Pre-Covid Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.4 Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.1 Pre-Covid Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.5 Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.1 Pre-Covid Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.6 Pre-Covid Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.6.1 Germany Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.2 France Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.3 U.K. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.4 Italy Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.5 Spain Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.7 Russia Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.8 Poland Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.9 Rest of Europe Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.7 Covid-19 Impact on Europe Ophthalmic Drugs Market
11.7.1 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.1.1 V-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.2 V-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.3 V-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.4 V-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.5 V-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.6 V-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.7 V-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.8 V-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2 UShaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.2.1 U-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.2 U-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.3 U-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.4 U-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.5 U-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.6 U-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.7 U-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.8 U-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.3.1 L-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.2 L-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.3 L-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.4 L-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.5 L-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.6 L-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.7 L-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.8 L-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.4.1 W-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.2 W-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.3 W-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.4 W-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.5 W-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.6 W-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.7 W-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.8 W-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
12. Asia Pacific Ophthalmic Drugs Market, 2020-2030
12.1 Asia Pacific Ophthalmic Drugs Market Overview
12.2 Asia Pacific Ophthalmic Drugs Market: Revenue Forecast 2020-2030
12.3 Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.4 Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.5 Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.6 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.6.1 China Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.1.1 Expansion of Healthcare Coverage and Reimbursement in China
12.6.1.2 Looming crunch for public health insurance
12.6.1.3 Pharmaceutical Pricing Policies in China
12.6.2 Japan Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.2.1 Pharmaceutical Policies and Reform in Japan
12.6.3 India Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.3.1 India: price controls and generic competition
12.6.3.2 Changing Healthcare infrastructure in India
12.6.4 Australia Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.5 South Korea Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.6 Rest of Asia Pacific Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.7 Covid-19 Impact on Asia Pacific Ophthalmic Drugs Market
12.7.1 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.2 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.3 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.4 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.1 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.1.1 V-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.2 V-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.3 V-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.4 V-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.1.6 V-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.2 UShaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.2.1 U-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.2 U-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.3 U-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.4 U-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.2.6 U-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.3 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.3.1 L-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.2 L-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.3 L-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.4 L-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.3.6 L-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.4 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.4.1 W-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.2 W-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.3 W-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.4 W-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.4.6 W-Shaped Recovery Rest of Asia Pacific Ophthalmic Drugs Market: Forecast 2020-2030
13. Latin America Ophthalmic Drugs Market, 2020-2030
13.1 Latin America Ophthalmic Drugs Market Overview
13.2 Latin America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
13.3 Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.4 Latin America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.1 Pre-Covid Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.2 V-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.3 U-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.4 L-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.5 W-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.5 Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.6 Pre-Covid Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.6.1 Brazil Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.6.2 Mexico Ophthalmic Drugs: Revenue Forecast, 2020-2030
13.6.3 Rest of Latin America Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.7 Covid-19 Impact on Latin America Ophthalmic Drugs Market
13.7.1 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.2 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.3 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.4 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.1 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.1.1 V-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.1.2 V-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.1.3 V-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2 U-shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.2.1 U-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2.2 U-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.2.3 U-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.3.1 L-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3.2 L-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.3.3 L-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.4.1 W-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4.2 W-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.4.3 W-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
14. Middle East & Africa Ophthalmic Drugs Market, 2020-2030
14.1 Middle East & Africa Ophthalmic Drugs Market Overview
14.2 Middle East & Africa Ophthalmic Drugs Market: Revenue Forecast 2020-2030
14.3 Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.4 Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.5 Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.6 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.6.1 Saudi Arabia Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.2 South Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.6.2.1 South Africa: has the Single Exit Price worked?
14.6.3 UAE Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.4 Rest of Middle East & Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.7 Covid-19 Impact on Middle East & Africa Ophthalmic Drugs Market
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.1.1 V-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.2 V-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.3 V-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.4 V-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.1.6 V-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2 U-shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2.1 U-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.2 U-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.3 U-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.4 U-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.2.6 U-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3.1 L-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.2 L-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.3 L-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.4 L-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.3.6 L-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4.1 W-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.2 W-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.3 W-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.4 W-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.4.6 W-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
15. Leading Companies in the Vaccine Contract Manufacturing Market, 2020-2030
15.1 Pre-Covid Leading Companies in the Ophthalmic Drugs Market, 2020
15.2 Novartis
15.2.1 Novartis: Ophthalmic Drugs Portfolio
15.2.2 Novartis AG: Financial Overview
15.2.3 Novartis: Sales Forecast, 2020-2030
15.2.4 Novartis: Ophthalmic Drugs Development Pipeline
15.2.5 Novartis: Recent Developments
15.3 Regeneron
15.3.1 Regeneron: Ophthalmic Drugs Portfolio
15.3.2 Regeneron: Financial Overview
15.3.3 Regeneron: Sales Forecast, 2020-2030
15.3.4 Regeneron: Ophthalmic Drugs Development Pipeline
15.3.5 Regeneron: Recent Developments
15.4 Allergan
15.4.2 Allergan: Financial Overview
15.4.3 Allergan: Sales Forecast, 2020-2030
15.4.4 Allergan: Ophthalmic Drugs Development Pipeline
15.4.5 Allergan: Recent Developments
15.5 Roche
15.5.1 Roche: Ophthalmic Drugs Portfolio
15.5.2 Roche: Financial Overview
15.5.3 Roche: Sales Forecast, 2020-2030
15.5.4 Roche: Ophthalmic Drugs Development Pipeline
15.5.5 Roche: Recent Developments
15.6 Santen Pharmaceutical Co.
15.6.1 Santen: Ophthalmic Drugs Portfolio
15.6.2 Santen: Financial Overview
15.6.3 Santen: Sales Forecast, 2020-2030
15.6.4 Santen: Ophthalmic Drugs Development Pipeline
15.6.5 Santen: Recent Developments
15.7 Bayer
15.7.1 Bayer: Ophthalmic Drugs Portfolio
15.7.2 Bayer: Financial Overview
15.7.2 Bayer: Financial Overview
15.8 Pfizer
15.8.1 Pfizer: Ophthalmic Drugs Portfolio
13.8.2 Pfizer: Financial Overview
15.8.3 Pfizer: Sales Forecast, 2020-2030
15.8.4 Pfizer: Ophthalmic Drugs Development Pipeline
15.8.5 Pfizer: Recent Developments
15.9 Senju Pharmaceutical Company Ltd (Senju)
15.9.1 Senju: Ophthalmic Drugs Portfolio
15.9.2 Senju: Ophthalmic Drugs Development Pipeline
15.9.3 Senju: Sales Forecast, 2020-2030
15.9.4 Senju: Recent Developments
15.10 Bausch Health Companies Inc.
15.10.1 Bausch Health Companies Inc.: Ophthalmic Drugs Portfolio
15.10.2 Bausch Health Companies Inc. AG: Financial Overview
15.10.3 Bausch Health: Sales Forecast, 2020-2030
15.10.4 Bausch Health Companies Inc: Ophthalmic Drugs Development Pipeline
15.10.5 Bausch Health Companies Inc.: Recent Developments
15.11 Akorn, Inc.
15.11.1 Akorn, Inc.: Ophthalmic Drugs Portfolio
15.11.2 Akorn, Inc. AG: Financial Overview
15.11.3 Akorn, Inc.: Sales Forecast, 2020-2030
15.11.4 Akorn, Inc.: Recent Developments
15.12 Sun Pharmaceutical Industries Ltd.
15.12.1 Sun Pharmaceutical Industries Ltd.: Ophthalmic Drugs Portfolio
15.12.2 Sun Pharmaceutical Industries Ltd. AG: Financial Overview
15.12.3 Sun Pharmaceutical: Ophthalmic Drugs Development Pipeline
15.12.4 Sun Pharmaceutical Industries Ltd. : Recent Developments
15.13 Aerie Pharmaceuticals Inc
15.13.1 Aerie Pharmaceuticals Inc.: Ophthalmic Drugs Portfolio
15.13.2 Aerie Pharmaceuticals Inc. AG: Financial Overview
15.13.3 Aerie Pharmaceuticals: Ophthalmic Drugs Development Pipeline
15.13.4 Aerie Pharmaceuticals Inc.: Recent Developments
15.14 Biogen
15.14.1 Biogen Inc.: Ophthalmic Drugs Portfolio
15.14.2 Biogen AG: Financial Overview
15.14.3 Biogen: Recent Developments
16. Ophthalmic Drugs: Research and Development Pipeline, 2020-2030
16.1 The Ophthalmic Drugs Pipeline: Intensive Development Efforts in Retinal Disorders
16.2 Drugs for Retinal Disorders: Development Pipeline
16.2.1 Will Bevasiranib (RXi Pharmaceuticals) Resume Development?
16.3 Retinal Disorders: Filed or Recently Launched
16.3.1 Beovu (brolucizumab) – Novartis
16.3.3 CompaqSipp (conbercept) – Chengdu Kanghong Pharmaceutical
16.3.3 Lipidil (fenofibrate) - Abbott
16.3.4 luvien (fluocinolone) – Alimera Sciences
16.4 Drugs in Phase 3 Development for Retinal Disorders
16.4.1 AGN150998 and MP0260 (Anti-VEGFDARPins) - Allergan
16.4.2 Fovista and Zimura – Ophthotech Corporation
16.4.3 Lampalizumab (anti-FactorD Fab) - Roche
16.4.4 MC-1101 (hydralazine) – Macu CLEAR
16.4.5 Squalamine (anti-angiogenic drug) - OHRPharmaceutical
16.4.6 Tandospirone (serotonin 1A agonist) – Alcon (Novartis)
16.4.7 UF-021 (unoprostone) - R-TechUeno
16.5 Drugs in Phase 2 Development for Retinal Disorders
16.5.1 AKB-9778 (Tie2 activator) - AerpioTherapeutics
16.5.2 Luminate (ALG-1001; Integrin peptide therapy) - Allegro/Senju
16.5.3 AGN208397 (beclomethasone) - Allergan
16.5.4 CPC 551 - Colby Pharmaceutical
16.5.5 ESBA1008 (anti-VEGF mAb) – Alcon (Novartis)
16.5.6 iCo-007 (antisense inhibitor of C-raf kinase mRNA) - iCo Therapeutics
16.5.7 LFG316 (anti-C5 mAb) - Novartis
16.5.8 Intravitreal brimonidine implant - Allergan
16.5.9 Optina (danazol) – Ampio Pharmaceuticals
16.5.10 PF-655 (synthetic siRNA) - Quark/Pfizer
16.5.11 Premiplex (SHP-607) - Shire
16.5.12 Renexus (ciliary neurotrophic factor) - Neurotech
16.5.13 Zybrestat (fosbretabulin) - Oxigene/Symphony VIDA
16.6 Drugs in Phase 1 and Pre-Clinical Development for Retinal Disorders
16.6.1 BDM-E - BioDiem
16.6.2 NADPHOxidaseInhibitors – AlimeraSciences
16.6.3 PAN-90806 (topical VEGF inhibitor) - PanOptica
16.6.5 QLT091001 (synthetic retinoid) – QLT
16.6.4 PlasmaKallikreinInhibitors (KVD001) - KalVista
16.7 Drugs in Phase 3 Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.7.1 EGP-437 (dexamethasone) – EyeGate Pharmaceuticals
16.7.2 IBI-10090 and IBI-20089 - Icon Bioscience
16.7.3 KPI-121 (loteprednol etabonate) - Kala
16.8 Drugs in Phase 2 Development for Allergic, Inflammatory And Infective Ophthalmic Conditions
16.8.1 CF101 (adenosine A3 receptor agonist) - Can-Fite BioPharma and OphthaliX
16.8.2 FST-100 (povidone-iodine/dexamethasone) - Shire
16.8.3 NVC-422 (auriclosene) - NovaBay
16.8.4 Sarilumab - Regeneron
16.9 Drugs in Phase 1 and Pre-Clinical Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.9.1 Finafloxacin – MerLion Pharmaceuticals/Novartis
16.10 Drugs for Glaucoma: Development Pipeline, 2020
16.10.1 Drugs in Phase 1 and Pre-Clinical Development for Glaucoma
16.11 Drugs in Phase 3 Development for Dry Eye
16.11.1 EBI-005 (IL-1R antagonist) – Eleven Bio therapeutics
16.11.2 Lifitegrast (integrin antagonist) - Shire
16.11.3 Tavilermide (formerly MIM-D3tyrosine kinase receptor antagonist) - Allergan
16.11.1 SI-614 (modified hyaluronate)-Siekagaku
16.12. Drugs in Phase 2 Development for Dry Eye
16.12.1 ESBA105 (TNF-alpha antibody) - Alcon (Novartis)
16.12.2 Kineret (anakinra: IL-1 receptor antagonist) - Amgen/Sobi
16.13 Other Drugs in the Development Pipeline for Ophthalmic Conditions
16.13.1 Brimonidine for Eye Whitening - Valeant
16.13.2 GS-101 (aganirsen) - GeneSignal
16.13.3 Omidria (phenylephrine/ketorolac) - Omeros
17. Conclusions
17.1 Overview of Current Market Conditions and Market Forecast, 2020-2030
17.3 Leading Regions in the Ophthalmic Drugs Market in 2020
17.4 Leading Companies in the Ophthalmic Drugs Market, 2020
17.5 What Does the Future Hold for Ophthalmic Drugs?
List of Tables
Table 1 Report Summary
Table 2 ICD-10 Classification of Visual Impairment, 2017
Table 3 Classification of Glaucoma
Table 4 Drug Treatments for AMD, 2020
Table 5 Drug Treatments for Ocular Allergy, 2020
Table 6 Drug Treatments for Ocular Inflammatory Disease, 2020
Table 7 Selected Drug Treatments for Eye Infections, 2020
Table 8 Clinical Trial Phases
Table 9 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 10 World 65+ Population Forecast: Size (m), AGR (%), 2017-2028
Table 11 Global Prevalence Forecast for Ophthalmic Diseases
Table 12 PESTEL Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 13 Global Ophthalmic Drugs Market Snapshot, 2020 & 2030 (US$ Mn, CAGR %)
Table 14 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 15 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 16 Pre-Covid Global ophthalmic drugs market by Indication: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 17 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 18 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 19 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 20 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 21 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 22 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 23 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 24 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 25 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 26 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 27 Pre-Covid Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 28 V-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 29 U-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 30 L-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 31 W-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 32 Pre-Covid Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 33 V-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 34 U-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 35 L-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 36 W-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 37 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 38 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 39 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 40 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 41 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 42 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 43 Pre-Covid Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 44 V-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 45 U-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 46 L-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 47 W-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 48 Pre-Covid Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 49 V-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 50 U-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 51 L-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 52 W-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 53 Pre-Covid Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 54 V-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 55 U-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 56 L-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 57 W-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 58 Global Retinal Disorder Drugs Market by Drugs, 2020
Table 59 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 60 V-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 61 U-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 62 L-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 63 W-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 64 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 65 Global Retinal Disorder Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 66 V-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 67 U-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 68 L-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 69 W-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 70 Global Eylea market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 71 Global Lucentis market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 72 Global Avastin market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 73 Global Visudyne market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 74 Global Jetrea market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 75 Global BEOVU market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 76 Global Allergic, Inflammatory & Infective Drugs Market by Drugs, 2020
Table 77 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 78 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 79 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 80 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 81 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 82 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 83 Global Allergic, Inflammatory & Infective Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 84 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 85 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 86 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 87 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 88 Global Pataday market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 89 Global Patanol market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 90 Global Vigamox market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 91 Global TobraDex market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 92 Global Cravit market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 93 Global Acular market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 94 Global AzaSite market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 95 Global Bromday market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 96 Global Glaucoma Drugs Market by Drugs, 2019
Table 97 Pre-Covid Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 98 V-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 99 U-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 100 L-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 101 W-Shaped Recovery Global glaucoma drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 102 Pre-Covid Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 103 Global Glaucoma Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 104 V-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 105 U-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 106 L-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 107 W-Shaped Recovery Global Glaucoma Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 108 Global Lumigan & Ganfort market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 109 Global Travatan & Duotrav market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 110 Global Alphagan & Combigan market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 111 Global Xalatan & Xalacom market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 112 Global Azopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 113 Global Cosopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 114 Global Tapros market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 115 Global Trusopt market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 116 Global Zioptan market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 117 Global Rhopressa market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 118 Global Dry Eye Drugs Market by Drugs, 2019
Table 119 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 120 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 121 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 122 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 123 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 124 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 125 Global Dry Eye Drugs market by Drugs: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 126 Global Restasis market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 127 Global Refresh market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 128 Global Hyalein market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 129 Global Diquas market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 130 Global Artelac market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 131 Global others dry eye drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 132 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 133 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 134 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 135 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 136 Global Ophthalmic Drugs Market by Region, By Revenue ($mn) and Market Share (%), 2020
Table 137 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 138 Pre-Covid Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 139 Global ophthalmic drugs market by Region: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 140 V-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 141 U-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 142 L-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 143 W-Shaped Recovery Global Dry Eye Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 144 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 145 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 146 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 147 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 148 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 149 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 150 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 151 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 152 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 153 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 154 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 155 V-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 156 U-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 157 L-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 158 W-Shaped Recovery North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 159 Pre-Covid North America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 160 North America ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 161 U.S. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 162 Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 163 V-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 164 V-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 165 U-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 166 U-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 167 L-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 168 L-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 169 W-Shaped Recovery US ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 170 W-Shaped Recovery Canada ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Country
Table 171 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 172 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 173 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 174 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 175 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 176 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 177 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 178 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 179 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 180 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 181 Pre-Covid Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 182 V-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 183 U-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 184 L-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 185 W-Shaped Recovery Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 186 Pre-Covid Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 187 Europe ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 188 Germany Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 189 France Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 190 U.K. Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 191 Italy Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 192 Spain Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 193 Russia Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 194 Poland Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 195 Rest of Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 196 V-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 197 V-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 198 V-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 199 V-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 200 V-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 201 V-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 202 V-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 203 V-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 204 V-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 205 U-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 206 U-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 207 U-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 208 U-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 209 U-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 210 U-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 211 U-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 212 U-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 213 U-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 214 L-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 215 L-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 216 L-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 217 L-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 218 L-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 219 L-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 220 L-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 221 L-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 222 L-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 223 W-Shaped Recovery Europe Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 224 W-Shaped Recovery Germany ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 225 W-Shaped Recovery France ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 226 W-Shaped Recovery U.K. ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 227 W-Shaped Recovery Italy ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 228 W-Shaped Recovery Spain ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 229 W-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 230 W-Shaped Recovery Poland ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 231 W-Shaped Recovery Rest of Europe ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 232 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 233 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 234 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 235 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 236 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 237 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 238 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 239 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 240 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 241 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 242 Pre-Covid Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 243 V-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 244 U-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 245 L-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 246 W-Shaped Recovery Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 247 Pre-Covid Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 248 Asia Pacific ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 249 China Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 250 Japan Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 251 India Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 252 Australia Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 253 South Korea Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 254 Rest of Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 255 V-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 256 V-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 257 V-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 258 V-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 259 V-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 260 V-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 261 V-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 262 U-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 263 U-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 264 U-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 265 U-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 266 U-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 267 U-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 268 U-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 269 L-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 270 L-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 271 L-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 272 L-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 273 L-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 274 L-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 275 L-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 276 W-Shaped Recovery Asia Pacific Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 277 W-Shaped Recovery China ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 278 W-Shaped Recovery Japan ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 279 W-Shaped Recovery India ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 280 W-Shaped Recovery Australia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 281 W-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 282 W-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 283 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 284 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 285 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 286 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 287 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 288 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 289 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 290 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 291 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 292 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 293 Pre-Covid Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 294 V-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 295 U-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 296 L-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 297 W-Shaped Recovery Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 298 Pre-Covid Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 299 Latin America ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 300 Brazil Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 301 Mexico Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 302 Rest of Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 303 V-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 304 V-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 305 V-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 306 V-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 307 U-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 308 U-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 309 U-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 310 U-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 311 L-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 312 L-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 313 L-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 314 L-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 315 W-Shaped Recovery Latin America Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 316 W-Shaped Recovery Brazil ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 317 W-Shaped Recovery Mexico ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 318 W-Shaped Recovery Rest of Latin America ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 319 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 320 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 321 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 322 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 323 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Indication
Table 324 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 325 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 326 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 327 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 328 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030, By Type
Table 329 Pre-Covid Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 330 V-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 331 U-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 332 L-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 333 W-Shaped Recovery Middle East & Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 334 Pre-Covid Middle East & Africa Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 335 Middle East & Africa ophthalmic drugs market by country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 336 V-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 337 V-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 338 V-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 339 V-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 340 V-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 341 U-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 342 U-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 343 U-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 344 U-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 345 U-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 346 L-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 347 L-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 348 L-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 349 L-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 350 L-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 351 W-Shaped Recovery MEA Ophthalmic Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 352 W-Shaped Recovery Saudi Arabia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 353 W-Shaped Recovery South Africa ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 354 W-Shaped Recovery UAE ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 355 W-Shaped Recovery Rest of MEA ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 356 Pre-Covid Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
Table 357 Novartis: Overview, 2020
Table 358 Novartis AG: Revenue ($m), AGR (%), 2015-2019
Table 359 Novartis: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 360 Regeneron: Overview, 2020
Table 361 Regeneron: Revenue ($m), AGR (%), 2015-2019
Table 362 Regeneron: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 363 Allergan: Overview, 2020
Table 364 Allergan: Revenue ($m), AGR (%), 2015-2019
Table 365 Allergan: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 366 Roche: Overview, 2020
Table 367 Roche: Revenue ($m), AGR (%), 2015-2019
Table 368 Roche: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 369 Santen: Overview, 2020
Table 370 Santen: Revenue ($m), AGR (%), 2015-2019
Table 371 Santen: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 372 Bayer: Overview, 2020
Table 373 Bayer: Revenue ($m), AGR (%), 2015-2019
Table 374 Bayer: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 375 Pfizer: Overview, 2020
Table 376 Pfizer: Revenue ($m), AGR (%), 2015-2019
Table 377 Pfizer: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 378 Senju: Overview, 2020
Table 379 Senju: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 380 Bausch Health Companies Inc. : Overview, 2020
Table 381 Bausch Health Companies Inc. AG: Revenue ($m), AGR (%), 2015-2019
Table 382 Bausch Health: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 383 Akorn, Inc. : Overview, 2020
Table 384 Akorn, Inc. AG: Revenue ($m), AGR (%), 2015-2019
Table 385 Akorn, Inc.: Ophthalmic Drugs Revenue Forecast ($m, AGR%, CAGR%), 2020-2030
Table 386 Sun Pharmaceutical Industries Ltd. : Overview, 2020
Table 387 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), AGR (%), 2015-2019
Table 388 Aerie Pharmaceuticals Inc : Overview, 2020
Table 389 Aerie Pharmaceuticals Inc AG: Revenue ($m), AGR (%), 2015-2019
Table 390 Biogen : Overview, 2020
Table 391 Biogen AG: Revenue ($m), AGR (%), 2015-2019
Table 392 Retinal Disorders Drugs Pipeline: Phase 3 Drugs
Table 393 Retinal Disorders Drugs Pipeline: Phase 2 Drugs
Table 394 Retinal Disorders Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 395 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 3 Drugs
Table 396 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 2 Drugs
Table 397 Allergic, Inflammatory and Infective Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 398 Glaucoma Drugs Pipeline: Phase 2&3 Drugs
Table 399 Glaucoma Drugs Pipeline: Phase 1 and Pre-clinical Drugs
Table 400 Dry Eye Drugs Pipeline: Phase 3 Drugs
Table 401 Dry Eye Drugs Pipeline: Phase 2 Drugs
Table 402 Other Pipeline Products for Ophthalmic Conditions
Table 403 Global Ophthalmic Drugs Market by Indication, 2019
Table 404 Global Ophthalmic Drugs Market by Region, 2020
Table 405 Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
List of Figures
Figure 1 Global Ophthalmic Drugs Market: Market Sectors, 2020
Figure 2 Structure of The Human Eye
Figure 3 Estimated Global Blindness and Visual Impairment (% of people), 2017
Figure 4 Global Causes of Visual Impairment (Million Cases)
Figure 5 Global Estimates of Numbers of People Affected by Selected Eye Conditions that Can Cause Vision Impairment (Million Cases)
Figure 6 Classification of Glaucoma
Figure 7 World 65+ Population Forecast: Size (m), AGR (%), 2017-2028
Figure 8 Global Prevalence of Diabetes and Diabetic Retinopathy, 2010 and 2030
Figure 9 Porter’s Five Force Analysis of the Ophthalmic Drugs Market, 2019
Figure 10 Global ophthalmic drugs market share, by indication, 2020 & 2030
Figure 11 Pre-Covid Global Ophthalmic Drugs Market, 2020-2030 ($m, AGR %)
Figure 12 Pre-Covid Global ophthalmic drugs market forecast by indication, 20 20
Figure 13 Pre-Covid Global ophthalmic drugs market forecast by indication, 2025
Figure 14 Pre-Covid Global ophthalmic drugs market forecast by indication, 2030
Figure 15 V-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 16 U-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 17 L-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 18 W-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 19 Global ophthalmic drugs market share, by type, 2020 & 2030
Figure 20 Global ophthalmic drugs market forecast (US$ Mn) by type, 20 20
Figure 21 Global ophthalmic drugs market (US$ Mn) forecast by type, 202 5
Figure 22 Global ophthalmic drugs market (US$ Mn) forecast by type, 2030
Figure 23 V-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 24 U-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 25 L-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 26 W-Shaped Recovery Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 27 Pre-Covid Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 28 V-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 29 U-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 30 L-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 31 W-Shaped Recovery Global prescription drugs market, 2020-2030 ($m, AGR%)
Figure 32 Pre-Covid Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 33 V-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 34 U-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 35 L-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 36 W-Shaped Recovery Global OTC drugs market, 2020-2030 ($m, AGR%)
Figure 37 Global ophthalmic drugs market share, by type, 2020 & 2030
Figure 38 Global ophthalmic drugs market (US$ Mn) forecast by type, 20 20
Figure 39 Global ophthalmic drugs market (US$ Mn) forecast by type, 202 5
Figure 40 Global ophthalmic drugs market (US$ Mn) forecast by type, 2030
Figure 41 Pre-Covid Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 42 V-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 43 U-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 44 L-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 45 W-Shaped Recovery Global hospital pharmacies market, 2020-2030 ($m, AGR%)
Figure 46 Pre-Covid Global drug stores market, 2020-2030 ($m, AGR%)
Figure 47 V-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 48 U-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 49 L-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 50 W-Shaped Recovery Global drug stores market, 2020-2030 ($m, AGR%)
Figure 51 Pre-Covid Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 52 V-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 53 U-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 54 L-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 55 W-Shaped Recovery Global online pharmacies market, 2020-2030 ($m, AGR%)
Figure 56 Global Retinal Disorder Drugs market share, by Drugs, 2020 & 2030
Figure 57 Pre-Covid Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 58 V-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 59 U-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 60 L-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 61 W-Shaped Recovery Global Retinal Disorder Drugs market, 2020-2030 ($m, AGR%)
Figure 62 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 2020
Figure 63 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 202 5
Figure 64 Global Retinal Disorder Drugs market (US$ Mn) forecast by Drugs, 2030
Figure 65 Global Eylea market, 2020-2030 ($m, AGR%)
Figure 66 Global Lucentis market, 2020-2030 ($m, AGR%)
Figure 67 Global Avastin market, 2020-2030 ($m, AGR%)
Figure 68 Global Visudyne market, 2020-2030 ($m, AGR %)
Figure 69 Global Jetrea market, 2020-2030 ($m, AGR %)
Figure 70 Global BEOVU market, 2020-2030 ($m, AGR%)
Figure 71 Global Allergic, Inflammatory & Infective Drugs market share, by Drugs, 2020 & 2030
Figure 72 Pre-Covid Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR %)
Figure 73 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 74 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 75 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 76 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs market, 2020-2030 ($m, AGR%)
Figure 77 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2020
Figure 78 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2025
Figure 79 Global Allergic, Inflammatory & Infective Drugs market forecast by Drugs, 2030
Figure 80 Global Pataday market, 2020-2030 ($m, AGR%)
Figure 81 Global Patanol market, 2020-2030 ($m, AGR%)
Figure 82 Global Vigamox market, 2020-2030 ($m, AGR%)
Figure 83 Global TobraDex market, 2020-2030 ($m, AGR%)
Figure 84 Global Cravit market, 2020-2030 ($m, AGR%)
Figure 85 Global Acular market, 2020-2030 ($m, AGR%)
Figure 86 Global AzaSite market, 2020-2030 ($m, AGR%)
Figure 87 Global Bromday market, 2020-2030 ($m, AGR%)
Figure 88 Global Glaucoma Drugs market share, by Drugs, 2020 & 2030
Figure 89 Pre-Covid Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 90 V-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 91 U-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 92 L-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 93 W-Shaped Recovery Global Glaucoma Drugs market, 2020-2030 ($m, AGR%)
Figure 94 Global Glaucoma Drugs market forecast by Drugs, 2020
Figure 95 Global Glaucoma Drugs market forecast by Drugs, 2025
Figure 96 Global Glaucoma Drugs market forecast by Drugs, 2030
Figure 97 Global Lumigan & Ganfort market, 2020-2030 ($m, AGR%)
Figure 98 Global Travatan & Duotrav market, 2020-2030 ($m, AGR%)
Figure 99 Global Alphagan & Combigan market, 2020-2030 ($m, AGR%)
Figure 100 Global Xalatan & Xalacom market, 2020-2030 ($m, AGR%)
Figure 101 Global Azopt market, 2020-2030 ($m, AGR%)
Figure 102 Global Cosopt market, 2020-2030 ($m, AGR%)
Figure 103 Global Tapros market, 2020-2030 ($m, AGR%)
Figure 104 Global Trusopt market, 2020-2030 ($m, AGR%)
Figure 105 Global Zioptan market, 2020-2030 ($m, AGR%)
Figure 106 Global Rhopressa market, 2020-2030 ($m, AGR%)
Figure 107 Pre-Covid Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 108 V-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 109 U-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 110 L-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 111 W-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 112 Global Dry Eye Drugs market forecast by Drugs, 2020
Figure 113 Global Dry Eye Drugs market forecast by Drugs, 2025
Figure 114 Global Dry Eye Drugs market forecast by Drugs, 2030
Figure 115 Global Restasis market, 2020-2030 ($m, AGR%)
Figure 116 Global Refresh market, 2020-2030 ($m, AGR%)
Figure 117 Global Hyalein market, 2020-2030 ($m, AGR%)
Figure 118 Global Diquas market, 2020-2030 ($m, AGR%)
Figure 119 Global Artelac market, 2020-2030 ($m, AGR%)
Figure 120 Global others dry eye drugs market, 2020-2030 ($m, AGR%)
Figure 121 V-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 122 U-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 123 L-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 124 W-Shaped Recovery Global Dry Eye Drugs market, 2020-2030 ($m, AGR%)
Figure 125 Global ophthalmic drugs market share, by Region, 20 20 & 2030
Figure 126 Pre-Covid Global ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 127 Global ophthalmic drugs market forecast by Region, 2020
Figure 128 Global ophthalmic drugs market forecast by Region, 2025
Figure 129 Global ophthalmic drugs market forecast by Region, 2030
Figure 130 Pre-Covid North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 131 V-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 132 U-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 133 L-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 134 W-Shaped Recovery North America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 135 North America ophthalmic drugs market share, by country, 2020 & 2030
Figure 136 North America ophthalmic drugs market forecast by Country, 2020
Figure 137 North America ophthalmic drugs market forecast by Country, 2025
Figure 138 North America ophthalmic drugs market forecast by Country, 2030
Figure 139 U.S ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 140 Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 141 V-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 142 V-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 143 U-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 144 V-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 145 L-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 146 L-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 147 W-Shaped Recovery US ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 148 W-Shaped Recovery Canada ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 149 Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 150 V-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 151 U-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 152 L-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR %)
Figure 153 W-Shaped Recovery Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 154 Europe ophthalmic drugs market share, by country, 2020 & 2030
Figure 155 Europe ophthalmic drugs market forecast by country, 2020
Figure 156 Europe ophthalmic drugs market forecast by country, 2025
Figure 157 Europe ophthalmic drugs market forecast by country, 2030
Figure 158 Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 159 France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 160 U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 161 Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 162 Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 163 Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 164 Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 165 Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 166 V-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 167 V-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 168 V-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 169 V-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 170 V-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 171 V-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 172 V-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 173 V-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 174 U-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 175 U-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 176 U-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 177 U-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 178 U-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 179 U-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 180 U-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 181 U-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 182 L-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 183 L-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 184 L-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 185 L-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 186 L-Shaped Recovery Spain ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 187 L-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 188 L-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 189 L-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 190 W-Shaped Recovery Germany ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 191 W-Shaped Recovery France ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 192 W-Shaped Recovery U.K. ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 193 W-Shaped Recovery Italy ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 194 W-Shaped Recovery Russia ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Figure 195 W-Shaped Recovery Russia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 196 W-Shaped Recovery Poland ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 197 W-Shaped Recovery Rest of Europe ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 198 Proportion of population aged 80 or older among the population aged 60 or older, by country or territory in East and North-East Asia, 1970–2050
Figure 199 Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 200 V-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 201 U-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 202 L-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 203 W-Shaped Recovery Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 204 Asia Pacific ophthalmic drugs market share, by country, 2020 & 2030
Figure 205 Asia Pacific ophthalmic drugs market forecast by country, 2020
Figure 206 Asia Pacific ophthalmic drugs market forecast by country, 2025
Figure 207 Asia Pacific ophthalmic drugs market forecast by country, 2030
Figure 208 V-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 209 V-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 210 V-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 211 V-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 212 V-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 213 V-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 214 U-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 215 U-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 216 U-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 217 U-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 218 U-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 219 U-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 220 L-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 221 L-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 222 L-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 223 L-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 224 L-Shaped Recovery South Korea ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 225 L-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 226 W-Shaped Recovery China ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 227 W-Shaped Recovery Japan ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 228 W-Shaped Recovery India ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 229 W-Shaped Recovery Australia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 230 W-Shaped Recovery South Korea ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Figure 231 W-Shaped Recovery Rest of Asia Pacific ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 232 Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 233 V-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 234 U-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 235 L-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 236 W-Shaped Recovery Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 237 Latin America ophthalmic drugs market share, by country, 2020 & 2030
Figure 238 Latin America ophthalmic drugs market forecast by type, 2025
Figure 239 Latin America ophthalmic drugs market forecast by type, 2030
Figure 240 Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 241 Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 242 Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 243 V-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 244 V-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 245 V-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 246 U-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 247 U-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 248 U-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 249 L-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 250 L-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 251 L-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 252 W-Shaped Recovery Brazil ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 253 W-Shaped Recovery Mexico ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 254 W-Shaped Recovery Rest of Latin America ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 255 Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 256 V-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR %)
Figure 257 U-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 258 L-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 259 W-Shaped Recovery Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 260 Middle East & Africa ophthalmic drugs market share, by country, 20 20 & 2030
Figure 261 Middle East & Africa ophthalmic drugs market forecast by type, 2020
Figure 262 Middle East & Africa ophthalmic drugs market forecast by type, 2025
Figure 263 Middle East & Africa ophthalmic drugs market forecast by type, 2030
Figure 264 Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 265 South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 266 UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 267 Rest of Middle East & Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 268 V-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 269 V-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 270 V-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 271 V-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 272 U-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 273 U-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 274 U-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 275 U-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 276 L-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 277 L-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 278 L-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 279 L-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 280 W-Shaped Recovery Saudi Arabia ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 281 W-Shaped Recovery South Africa ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 282 W-Shaped Recovery UAE ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 283 W-Shaped Recovery Rest of MEA ophthalmic drugs market, 2020-2030 ($m, AGR%)
Figure 284 Leading Ophthalmic Drug Companies: Revenues ($m) and Market Shares (%), 2019
Figure 285 Novartis AG: Revenue ($m), 2015-2019
Figure 286 Novartis AG: Revenue ($m), By Segment, 2019
Figure 287 Novartis AG: Revenue ($m), By Region, 2019
Figure 288 Novartis: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 289 Regeneron: Revenue ($m), 2015-2019
Figure 290 Regeneron: Revenue ($m), By Segment, 2019
Figure 291 Regeneron: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 292 Allergan: Revenue ($m), 2015-2019
Figure 293 Allergan: Revenue ($m), By Product, 2019
Figure 294 Allergan: Revenue ($m), By Segment, 2019
Figure 295 Allergan: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 296 Roche: Revenue ($m), 2015-2019
Figure 297 Roche: Revenue ($m), By Division, 2019
Figure 298 Roche: Revenue ($m), By Region, 2019
Figure 299 Roche: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 300 Santen: Revenue ($m), 2015-2019
Figure 301 Santen: Revenue ($m), By Region, 2019
Figure 302 Santen: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 303 Bayer: Revenue ($m), 2015-2019
Figure 304 Bayer: Revenue ($m), By Division, 2019
Figure 305 Bayer: Revenue ($m), By Region, 2019
Figure 306 Bayer: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 307 Pfizer: Revenue ($m), 2015-2019
Figure 308 Pfizer: Revenue ($m), By Segment, 2019
Figure 309 Pfizer: Revenue ($m), By Region, 2019
Figure 310 Pfizer: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 311 Senju: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 312 Bausch Health Companies Inc. AG: Revenue ($m), 2015-2019
Figure 313 Bausch Health Companies Inc. AG: Revenue ($m), By Segment, 2019
Figure 314 Bausch Health Companies Inc. AG: Revenue ($m), By Region, 2019
Figure 315 Bausch Health: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 316 Akorn, Inc. AG: Revenue ($m), 2015-2019
Figure 317 Akorn, Inc. AG: Revenue ($m), By Segment, 2019
Figure 318 Akorn, Inc. AG: Revenue ($m), By Customer, 2019
Figure 319 Akorn, Inc.: Ophthalmic Drugs Revenue Forecast ($m, AGR%), 2020-2030
Figure 320 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), 2015-2019
Figure 321 Sun Pharmaceutical Industries Ltd. AG: Revenue ($m), By Segment, 2019
Figure 322 Aerie Pharmaceuticals Inc AG: Revenue ($m, % AGR), 2015-2019
Figure 323 Biogen AG: Revenue ($m), 2015-2019
Figure 324 Biogen AG: Revenue ($m), By Segment, 2019
Figure 325 Biogen AG: Revenue ($m), By Region, 2019
Figure 326 Global ophthalmic drugs market, 2020-2030 ($m, % AGR)
Figure 327 Global ophthalmic drugs market share, by indication, 2020 & 2030
Figure 328 Global ophthalmic drugs market share, by Region, 2020 & 2030
Companies Profiled in the Report
Aerie Pharmaceuticals Inc
Akorn, Inc.
Allergan
Bausch Health Companies Inc.
Bayer
Biogen
Novartis
Pfizer
Regeneron
Roche
Santen Pharmaceutical Co.
Senju Pharmaceutical Company Ltd (Senju)
Sun Pharmaceutical Industries Ltd.
List of Companies Mentioned in the Report
Abbott Laboratories (Abbott)
Abbvie
Actavis
Acucela
Advanced Vision Research (acquired by Akorn)
Aerie Pharmaceuticals
Aerpio Therapeutics
Akorn Pharmaceuticals
Alcon (subsidiary of Novartis)
Alimera Sciences
Allegro Ophthalmics
Allergan
Altheos
Amakem
Ampio Pharma
Asahi Glass
AstraZeneca
Aton Pharma (acquired by Valeant)
Banyu Pharmaceutical (part of Merck)
Bausch and Lomb (subsidiary of Valeant)
Bayer
Bayer Yakuhin (Japanese subsidiary of Bayer)
Bicycle Therapeutics
BioDiem
Biogen Idec
BioInvent International
Biovail Corporation (part of Valeant)
Bristol-Myers Squibb
Can-Fite BioPharma
Chengdu Kanghong Pharmaceutical
Chiron Corportation (part of Novartis)
Chugai Pharmaceutical (part of Roche)
CIBA VISION (part of Novartis)
Ciba-Geigy (part of Novartis)
Colby Pharmaceutical Company (Colby)
CoMentis
Daiichi Sankyo
Eleven Biotherapeutics
Eli Lilly and Company (Lilly)
EyeGate Pharmaceuticals
Eyetech Inc. / Eyetech Pharmaceuticals (acquired by Valeant)
Fougera Pharmaceuticals (acquired by Novartis)
Gene Signal
Genentech (subsidiary of Roche)
Genzyme (subsidiary of Sanofi)
Gilead Sciences
GSK
ICN Pharmaceuticals (original Valeant company)
Icon Bioscience
Inamed Corporation (subsidiary of Allergan)
Inception Sciences, Inc.
InSite Vision
Inspire Pharmaceuticals (acquired by Merck)
ISTA Pharmaceuticals (part of Valeant)
Jerini AG
Jerini Ophthalmic (part of Jerini AG)
Johnson & Johnson
Kestrel Ophthalmics
Kyorin Pharmaceutical
Kyowa Hakko Kirin
LEO Pharma
Lpath
MacuCLEAR
MacuSIGHT, Inc.
MAP Pharmaceuticals (acquired by Allergan)
Meda
Medicis Corporation (acquired by Valeant)
Merck & Co. (Merck)
MerLion Pharmaceuticals
MSD K.K. (part of Merck)
Mylan Pharmaceuticals
Mystic Pharmaceuticals
Neurotech
NicOx
Nippon Boehringer Ingelheim (subsidiary of Boehringer Ingelheim)
NovaBay Pharmaceuticals
Novagali Pharma (acquired by Santen)
Novartis
Novo (subsidiary of Novo Nordisk)
Novo Nordisk
Oakwood Laboratories
OcuSciences
Omeros
Onyx Pharmaceuticals
OphthaliX (part-owned by Can-Fite BioPharma)
Ophthotech
OPKO Health
Ora
OSI Pharmaceuticals
Othera Pharmaceuticals (acquired by Colby)
Otsuka Pharmaceutical
Oxford BioMedica
OXiGENE
Parke-Davis (subsidiary of Pfizer)
PDL BioPharma
Pfizer
Pharmacia (acquired by Pfizer)
Potentia Pharmaceuticals
Premacure
Procter & Gamble
pSivida
Quark Pharmaceuticals
Reckitt Benckiser
Regeneron
RetroSense Therapeutics
ReVision Therapeutics
Roche
RXi Pharmaceuticals
Sandoz (part of Novartis)
Sanofi
Santen Pharmaceutical Co. (Santen)
SARcode Bioscience
Schering-Plough (part of Merck)
Senju
Senju Pharmaceuticals Science & Technology (Beijing) Co., Ltd. (subsidiary of Senju)
Senju USA Inc. (subsidiary of Senju)
Shire
Sirion Therapeutics
Sirna Therapeutics
Sirnaomics
SkinMedica (subsidiary of Allergan)
Spark Therapeutics
Symphony ViDA
Takeda Pharmaceutical
Teva
The Patent Board
ThromboGenics
Upjohn (acquired by Pfizer through Pharmacia)
Valeant Pharmaceuticals
Ventana Medical Systems (acquired by Roche)
Versant Ventures
Warburg Pincus LLC
Warner-Lambert (acquired by Pfizer)
Watson Pharmaceuticals
Wyeth Pharmaceuticals (part of Pfizer)
List of Organizations Mentioned in the Report: Minimum 20 Organizations are Required
A*STAR Institute for Infocomm Research (Singapore)
American Academy of Ophthalmology (AAO)
American Diabetes Association
American Society of Retina Specialists (ASRS)
Association for Research in Vision and Ophthalmology (ARVO)
Council of Europe
Emory University
European Medicines Agency (EMA)
Foundation Fighting Blindness (FFB) (US)
Health Canada
Institute of Experimental Medicine (Russia)
Institute of Ocular Pharmacology, Texas A&M (US)
Institute of Ophthalmology, University College London (UK)
Intellectual Property Appellate Board (India)
International Diabetes Federation
Internet Archive
Japan Patent Office (JPO)
Mayo Clinic
Ministry of Health, Labour and Welfare (MHLW) (Japan)
Monash University
National Eye Institute (NEI) (US)
National Health Service (NHS) (UK)
National Institute for Health and Care Excellence (NICE) (UK)
NHS Scotland
Novartis Institutes for BioMedical Research (NIBR) (part of Novartis)
Novartis Venture Funds (NVF) (part of Novartis)
Ophthalmology External Research Unit (part of Pfizer)
Ophthrisi (GSK research unit)
Rinat (Pfizer research unit)
Texas Emerging Technology Fund
Therapeutic Goods Administration (TGA) (Australia)
Tokyo University of Science
United States Food and Drug Administration (FDA)
University of Florida
University of Kentucky
University of Melbourne
University of Michigan
US Preventive Services Task Force (USPSTF)
US Securities and Exchange Commission (SEC)
World Health Organization (WHO)
Aerie Pharmaceuticals Inc
Akorn, Inc.
Allergan
Bausch Health Companies Inc.
Bayer
Biogen
Novartis
Pfizer
Regeneron
Roche
Santen Pharmaceutical Co.
Senju Pharmaceutical Company Ltd (Senju)
Sun Pharmaceutical Industries Ltd.
List of Companies Mentioned in the Report
Abbott Laboratories (Abbott)
Abbvie
Actavis
Acucela
Advanced Vision Research (acquired by Akorn)
Aerie Pharmaceuticals
Aerpio Therapeutics
Akorn Pharmaceuticals
Alcon (subsidiary of Novartis)
Alimera Sciences
Allegro Ophthalmics
Allergan
Altheos
Amakem
Ampio Pharma
Asahi Glass
AstraZeneca
Aton Pharma (acquired by Valeant)
Banyu Pharmaceutical (part of Merck)
Bausch and Lomb (subsidiary of Valeant)
Bayer
Bayer Yakuhin (Japanese subsidiary of Bayer)
Bicycle Therapeutics
BioDiem
Biogen Idec
BioInvent International
Biovail Corporation (part of Valeant)
Bristol-Myers Squibb
Can-Fite BioPharma
Chengdu Kanghong Pharmaceutical
Chiron Corportation (part of Novartis)
Chugai Pharmaceutical (part of Roche)
CIBA VISION (part of Novartis)
Ciba-Geigy (part of Novartis)
Colby Pharmaceutical Company (Colby)
CoMentis
Daiichi Sankyo
Eleven Biotherapeutics
Eli Lilly and Company (Lilly)
EyeGate Pharmaceuticals
Eyetech Inc. / Eyetech Pharmaceuticals (acquired by Valeant)
Fougera Pharmaceuticals (acquired by Novartis)
Gene Signal
Genentech (subsidiary of Roche)
Genzyme (subsidiary of Sanofi)
Gilead Sciences
GSK
ICN Pharmaceuticals (original Valeant company)
Icon Bioscience
Inamed Corporation (subsidiary of Allergan)
Inception Sciences, Inc.
InSite Vision
Inspire Pharmaceuticals (acquired by Merck)
ISTA Pharmaceuticals (part of Valeant)
Jerini AG
Jerini Ophthalmic (part of Jerini AG)
Johnson & Johnson
Kestrel Ophthalmics
Kyorin Pharmaceutical
Kyowa Hakko Kirin
LEO Pharma
Lpath
MacuCLEAR
MacuSIGHT, Inc.
MAP Pharmaceuticals (acquired by Allergan)
Meda
Medicis Corporation (acquired by Valeant)
Merck & Co. (Merck)
MerLion Pharmaceuticals
MSD K.K. (part of Merck)
Mylan Pharmaceuticals
Mystic Pharmaceuticals
Neurotech
NicOx
Nippon Boehringer Ingelheim (subsidiary of Boehringer Ingelheim)
NovaBay Pharmaceuticals
Novagali Pharma (acquired by Santen)
Novartis
Novo (subsidiary of Novo Nordisk)
Novo Nordisk
Oakwood Laboratories
OcuSciences
Omeros
Onyx Pharmaceuticals
OphthaliX (part-owned by Can-Fite BioPharma)
Ophthotech
OPKO Health
Ora
OSI Pharmaceuticals
Othera Pharmaceuticals (acquired by Colby)
Otsuka Pharmaceutical
Oxford BioMedica
OXiGENE
Parke-Davis (subsidiary of Pfizer)
PDL BioPharma
Pfizer
Pharmacia (acquired by Pfizer)
Potentia Pharmaceuticals
Premacure
Procter & Gamble
pSivida
Quark Pharmaceuticals
Reckitt Benckiser
Regeneron
RetroSense Therapeutics
ReVision Therapeutics
Roche
RXi Pharmaceuticals
Sandoz (part of Novartis)
Sanofi
Santen Pharmaceutical Co. (Santen)
SARcode Bioscience
Schering-Plough (part of Merck)
Senju
Senju Pharmaceuticals Science & Technology (Beijing) Co., Ltd. (subsidiary of Senju)
Senju USA Inc. (subsidiary of Senju)
Shire
Sirion Therapeutics
Sirna Therapeutics
Sirnaomics
SkinMedica (subsidiary of Allergan)
Spark Therapeutics
Symphony ViDA
Takeda Pharmaceutical
Teva
The Patent Board
ThromboGenics
Upjohn (acquired by Pfizer through Pharmacia)
Valeant Pharmaceuticals
Ventana Medical Systems (acquired by Roche)
Versant Ventures
Warburg Pincus LLC
Warner-Lambert (acquired by Pfizer)
Watson Pharmaceuticals
Wyeth Pharmaceuticals (part of Pfizer)
List of Organizations Mentioned in the Report: Minimum 20 Organizations are Required
A*STAR Institute for Infocomm Research (Singapore)
American Academy of Ophthalmology (AAO)
American Diabetes Association
American Society of Retina Specialists (ASRS)
Association for Research in Vision and Ophthalmology (ARVO)
Council of Europe
Emory University
European Medicines Agency (EMA)
Foundation Fighting Blindness (FFB) (US)
Health Canada
Institute of Experimental Medicine (Russia)
Institute of Ocular Pharmacology, Texas A&M (US)
Institute of Ophthalmology, University College London (UK)
Intellectual Property Appellate Board (India)
International Diabetes Federation
Internet Archive
Japan Patent Office (JPO)
Mayo Clinic
Ministry of Health, Labour and Welfare (MHLW) (Japan)
Monash University
National Eye Institute (NEI) (US)
National Health Service (NHS) (UK)
National Institute for Health and Care Excellence (NICE) (UK)
NHS Scotland
Novartis Institutes for BioMedical Research (NIBR) (part of Novartis)
Novartis Venture Funds (NVF) (part of Novartis)
Ophthalmology External Research Unit (part of Pfizer)
Ophthrisi (GSK research unit)
Rinat (Pfizer research unit)
Texas Emerging Technology Fund
Therapeutic Goods Administration (TGA) (Australia)
Tokyo University of Science
United States Food and Drug Administration (FDA)
University of Florida
University of Kentucky
University of Melbourne
University of Michigan
US Preventive Services Task Force (USPSTF)
US Securities and Exchange Commission (SEC)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Drugs Market Report to 2030Related reports
-
Global Optometry/Eye Exam Equipment Market 2019-2029
Optometry/Eye examination equipment are required for the diagnosis, examination of an eye and treatment of various eye diseases such as...
Full DetailsPublished: 01 January 1970 -
Global Ophthalmic Surgical Instruments Market 2019-2029
Ophthalmology is a branch of medical sciences that deals with the anatomical and physiological study of eyes such as function,...
Full DetailsPublished: 01 January 1970 -
Ophthalmic Devices Market Report 2022-2032
The number of people who are blind or have poor vision is expected to rise considerably in the coming years....Full DetailsPublished: 19 April 2022 -
Ophthalmic Ultrasound Systems Market Report 2020-2030
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases,...
Full DetailsPublished: 07 September 2020 -
Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031
The global market for ophthalmic drugs is increasing yearly. Your competitors in the ophthalmic drugs market are benefiting from key...Full DetailsPublished: 04 March 2021 -
The Ophthalmic Equipment Market Forecast 2019-2029
Ophthalmology is a branch of medical sciences that deals with the anatomical and physiological study of eyes such as function,...Full DetailsPublished: 31 May 2019 -
Global Ophthalmic Devices Market 2020-2030
The global ophthalmic devices market is expected to grow at a CAGR of 4.9% in the first half of the...
Full DetailsPublished: 12 March 2020 -
Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2021-2031
Rising investment in drug R&D by pharmaceutical and biopharmaceutical companies, increasing prevalence of retinal diseases, mounting demand for biologics &...Full DetailsPublished: 11 February 2021 -
Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029
The global ophthalmic drugs market was valued at $25bn in 2018. The market was dominated by the Retinal Disorder drug...Full DetailsPublished: 15 August 2019 -
Ophthalmic Packaging Market Report 2020-2030
Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends,...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Drugs Market Report to 2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Peripheral Vascular Device Market Report 2024-2034
The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
30 April 2024
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
